Publications of Andrew D. Krystal

Papers Published

  1. Watson, NF; Bertisch, SM; Morin, CM; Pelayo, R; Winkelman, JW; Zee, PC; Krystal, AD, Do Insomnia Treatments Improve Daytime Function?, Journal of Clinical Medicine, vol. 12 no. 9 (April, 2023)
  2. Pelayo, R; Bertisch, SM; Morin, CM; Winkelman, JW; Zee, PC; Krystal, AD, Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal., Journal of Clinical Medicine, vol. 12 no. 8 (April, 2023)
  3. Sellers, KK; Stapper, N; Astudillo Maya, DA; Henderson, C; Khambhati, AN; Fan, JM; Rao, VR; Scangos, KW; Chang, EF; Krystal, AD, Changes in intracranial neurophysiology associated with acute COVID-19 infection., Clin Neurophysiol, vol. 148 (April, 2023), pp. 29-31
  4. Watson, NF; Benca, RM; Krystal, AD; McCall, WV; Neubauer, DN, Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia., Journal of Clinical Medicine, vol. 12 no. 7 (March, 2023)
  5. Benca, RM; Bertisch, SM; Ahuja, A; Mandelbaum, R; Krystal, AD, Wake Up America: National Survey of Patients' and Physicians' Views and Attitudes on Insomnia Care., Journal of Clinical Medicine, vol. 12 no. 7 (March, 2023)
  6. Morin, CM; Bertisch, SM; Pelayo, R; Watson, NF; Winkelman, JW; Zee, PC; Krystal, AD, What Should Be the Focus of Treatment When Insomnia Disorder Is Comorbid with Depression or Anxiety Disorder?, Journal of Clinical Medicine, vol. 12 no. 5 (March, 2023)
  7. Zee, PC; Bertisch, SM; Morin, CM; Pelayo, R; Watson, NF; Winkelman, JW; Krystal, AD, Long-Term Use of Insomnia Medications: An Appraisal of the Current Clinical and Scientific Evidence., Journal of Clinical Medicine, vol. 12 no. 4 (February, 2023)
  8. Benca, RM; Krystal, A; Chepke, C; Doghramji, K, Recognition and Management of Obstructive Sleep Apnea in Psychiatric Practice., The Journal of Clinical Psychiatry, vol. 84 no. 2 (January, 2023)
  9. Ohayon, MM; McCue, M; Krystal, A; Selzler, KJ; Chrones, L; Lawrence, D; Côté, M-L, Longitudinal study to assess antidepressant treatment patterns and outcomes in individuals with depression in the general population., J Affect Disord, vol. 321 (January, 2023), pp. 272-278
  10. Epperson, CN; Rubinow, DR; Meltzer-Brody, S; Deligiannidis, KM; Riesenberg, R; Krystal, AD; Bankole, K; Huang, M-Y; Li, H; Brown, C; Kanes, SJ; Lasser, R, Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program., J Affect Disord, vol. 320 (January, 2023), pp. 353-359
  11. Fan, JM; Khambhati, AN; Sellers, KK; Stapper, N; Maya, DA; Kunwar, E; Henderson, C; Sugrue, LP; Scangos, KW; Chang, EF; Rao, VR; Krystal, AD, Epileptiform discharges triggered with direct electrical stimulation for treatment-resistant depression: Factors that modulate risk and treatment considerations., Brain Stimul, vol. 16 no. 2 (2023), pp. 462-465
  12. Krystal, AD; Benca, RM; Rosenberg, R; Schweitzer, PK; Malhotra, A; Babson, K; Lee, L; Bujanover, S; Strohl, KP, Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression., J Psychiatr Res, vol. 155 (November, 2022), pp. 202-210
  13. Scangos, KW; Makhoul, GS; Sugrue, LP; Chang, EF; Krystal, AD, Publisher Correction: State-dependent responses to intracranial brain stimulation in a patient with depression., Nat Med, vol. 28 no. 10 (October, 2022), pp. 2218
  14. Chang, JL; Goldberg, AN; Alt, JA; Mohammed, A; Ashbrook, L; Auckley, D; Ayappa, I; Bakhtiar, H; Barrera, JE; Bartley, BL; Billings, ME; Boon, MS; Bosschieter, P; Braverman, I; Brodie, K; Cabrera-Muffly, C; Caesar, R; Cahali, MB; Cai, Y; Cao, M; Capasso, R; Caples, SM; Chahine, LM; Chang, CP; Chang, KW; Chaudhary, N; Cheong, CSJ; Chowdhuri, S; Cistulli, PA; Claman, D; Collen, J; Coughlin, KC; Creamer, J; Davis, EM; Dupuy-McCauley, KL; Durr, ML; Dutt, M; Ali, ME; Elkassabany, NM; Epstein, LJ; Fiala, JA; Freedman, N; Gill, K; Gillespie, MB; Golisch, L; Gooneratne, N; Gottlieb, DJ; Green, KK; Gulati, A; Gurubhagavatula, I; Hayward, N; Hoff, PT; Hoffmann, OMG; Holfinger, SJ; Hsia, J; Huntley, C; Huoh, KC; Huyett, P; Inala, S; Ishman, SL; Jella, TK; Jobanputra, AM; Johnson, AP; Junna, MR; Kado, JT; Kaffenberger, TM; Kapur, VK; Kezirian, EJ; Khan, M; Kirsch, DB; Kominsky, A; Kryger, M; Krystal, AD; Kushida, CA; Kuzniar, TJ; Lam, DJ; Lettieri, CJ; Lim, DC; Lin, H-C; Liu, SYC; MacKay, SG; Magalang, UJ; Malhotra, A; Mansukhani, MP; Maurer, JT; May, AM; Mitchell, RB; Mokhlesi, B; Mullins, AE; Nada, EM; Naik, S; Nokes, B; Olson, MD; Pack, AI; Pang, EB; Pang, KP; Patil, SP; Van de Perck, E; Piccirillo, JF; Pien, GW; Piper, AJ; Plawecki, A; Quigg, M; Ravesloot, MJL; Redline, S; Rotenberg, BW; Ryden, A; Sarmiento, KF; Sbeih, F; Schell, AE; Schmickl, CN; Schotland, HM; Schwab, RJ; Seo, J; Shah, N; Shelgikar, AV; Shochat, I; Soose, RJ; Steele, TO; Stephens, E; Stepnowsky, C; Strohl, KP; Sutherland, K; Suurna, MV; Thaler, E; Thapa, S; Vanderveken, OM; de Vries, N; Weaver, EM; Weir, ID; Wolfe, LF; Woodson, BT; Won, CHJ; Xu, J; Yalamanchi, P; Yaremchuk, K; Yeghiazarians, Y; Yu, JL; Zeidler, M; Rosen, IM, International Consensus Statement on Obstructive Sleep Apnea., Int Forum Allergy Rhinol (September, 2022)
  15. Culpepper, L; Krystal, AD; Pinner, K; Moline, M, Post Hoc Analysis of the Impact of Lemborexant on Patient-Reported Sleep and Insomnia Severity in Adults with Insomnia and Depression Histories., Cns Spectrums, vol. 27 no. 2 (April, 2022), pp. 243
  16. Felder, JN; Mirchandaney, R; Harrison, J; Manber, R; Cuneo, J; Krystal, A; Epel, E; Hecht, F, Examining Experiences of Poor Sleep During Pregnancy: A Qualitative Study to Inform the Development of a Prenatal Sleep Intervention, Global Advances in Health and Medicine, vol. 11 (March, 2022)
  17. Sforzini, L; Worrell, C; Kose, M; Anderson, IM; Aouizerate, B; Arolt, V; Bauer, M; Baune, BT; Blier, P; Cleare, AJ; Cowen, PJ; Dinan, TG; Fagiolini, A; Ferrier, IN; Hegerl, U; Krystal, AD; Leboyer, M; McAllister-Williams, RH; McIntyre, RS; Meyer-Lindenberg, A; Miller, AH; Nemeroff, CB; Normann, C; Nutt, D; Pallanti, S; Pani, L; Penninx, BWJH; Schatzberg, AF; Shelton, RC; Yatham, LN; Young, AH; Zahn, R; Aislaitner, G; Butlen-Ducuing, F; Fletcher, C; Haberkamp, M; Laughren, T; Mäntylä, F-L; Schruers, K; Thomson, A; Arteaga-Henríquez, G; Benedetti, F; Cash-Gibson, L; Chae, WR; De Smedt, H; Gold, SM; Hoogendijk, WJG; Mondragón, VJ; Maron, E; Martynowicz, J; Melloni, E; Otte, C; Perez-Fuentes, G; Poletti, S; Schmidt, ME; van de Ketterij, E; Woo, K; Flossbach, Y; Ramos-Quiroga, JA; Savitz, AJ; Pariante, CM, A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials., Mol Psychiatry, vol. 27 no. 3 (March, 2022), pp. 1286-1299
  18. Whitehurst, LN; Subramoniam, A; Krystal, A; Prather, AA, Links between the brain and body during sleep: implications for memory processing., Trends Neurosci, vol. 45 no. 3 (March, 2022), pp. 212-223
  19. Felder, JN; Epel, ES; Neuhaus, J; Krystal, AD; Prather, AA, Randomized controlled trial of digital cognitive behavior therapy for prenatal insomnia symptoms: effects on postpartum insomnia and mental health., Sleep, vol. 45 no. 2 (February, 2022)
  20. Arnedt, JT; Cardoni, ME; Conroy, DA; Graham, M; Amin, S; Bohnert, KM; Krystal, AD; Ilgen, MA, Telemedicine-delivered cognitive-behavioral therapy for insomnia in alcohol use disorder (AUD): study protocol for a randomized controlled trial., Trials, vol. 23 no. 1 (January, 2022), pp. 59
  21. Wickwire, EM; Albrecht, JS; Capaldi, VF; Jain, SO; Gardner, RC; Werner, JK; Mukherjee, P; McKeon, AB; Smith, MT; Giacino, JT; Nelson, LD; Williams, SG; Collen, J; Sun, X; Schnyer, DM; Markowitz, AJ; Manley, GT; Krystal, AD; Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Investigators,, Trajectories of Insomnia in Adults After Traumatic Brain Injury., Jama Network Open, vol. 5 no. 1 (January, 2022), pp. e2145310
  22. Lunsford-Avery, JR; Edinger, JD; Krystal, AD, Overnight Delta Dynamics Associated with Daytime Psychomotor Performance in Adults with Insomnia and Healthy Controls., Nature and Science of Sleep, vol. 14 (2022), pp. 217-230
  23. Krystal, AD; Ashbrook, LH; Prather, AA, What Is Insomnia?, Jama, vol. 326 no. 23 (December, 2021), pp. 2444
  24. McCall, WV; Porter, B; Pate, AR; Bolstad, CJ; Drapeau, CW; Krystal, AD; Benca, RM; Rumble, ME; Nadorff, MR, Examining suicide assessment measures for research use: Using item response theory to optimize psychometric assessment for research on suicidal ideation in major depressive disorder., Suicide and Life Threatening Behavior, vol. 51 no. 6 (December, 2021), pp. 1086-1094
  25. Pizzagalli, DA; Smoski, M; Ang, Y-S; Whitton, AE; Sanacora, G; Mathew, SJ; Nurnberger, J; Lisanby, SH; Iosifescu, DV; Murrough, JW; Yang, H; Weiner, RD; Calabrese, JR; Goodman, W; Potter, WZ; Krystal, AD, Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)., Neuropsychopharmacology, vol. 46 no. 12 (November, 2021), pp. 2224
  26. Scangos, KW; Khambhati, AN; Daly, PM; Makhoul, GS; Sugrue, LP; Zamanian, H; Liu, TX; Rao, VR; Sellers, KK; Dawes, HE; Starr, PA; Krystal, AD; Chang, EF, Closed-loop neuromodulation in an individual with treatment-resistant depression., Nat Med, vol. 27 no. 10 (October, 2021), pp. 1696-1700
  27. Krystal, JH; Chow, B; Vessicchio, J; Henrie, AM; Neylan, TC; Krystal, AD; Marx, BP; Xu, K; Jindal, RD; Davis, LL; Schnurr, PP; Stein, MB; Thase, ME; Ventura, B; Huang, GD; Shih, M-C; CSP 2016 Study Team,, Design of the National Adaptive Trial for PTSD-related Insomnia (NAP Study), VA Cooperative Study Program (CSP) #2016., Contemp Clin Trials, vol. 109 (October, 2021), pp. 106540
  28. Rosenberg, RP; Krystal, AD, Diagnosing and Treating Insomnia in Adults and Older Adults., The Journal of Clinical Psychiatry, vol. 82 no. 6 (September, 2021)
  29. Krystal, AD, Optimizing Treatment for Insomnia., The Journal of Clinical Psychiatry, vol. 82 no. 4 (July, 2021), pp. EI20008BR4C
  30. Insel, PS; Mohlenhoff, BS; Neylan, TC; Krystal, AD; Mackin, RS, Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults., Jama Network Open, vol. 4 no. 7 (July, 2021), pp. e2117573
  31. Zammit, G; Krystal, A, Evaluating lemborexant for the treatment of insomnia., Expert Opinion on Pharmacotherapy, vol. 22 no. 10 (July, 2021), pp. 1235-1243
  32. Krystal, AD, Challenges in Managing Insomnia in Older People., The Journal of Clinical Psychiatry, vol. 82 no. 4 (June, 2021)
  33. Darden, M; Espie, CA; Carl, JR; Henry, AL; Kanady, JC; Krystal, AD; Miller, CB, Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States., Sleep, vol. 44 no. 4 (April, 2021), pp. zsaa223
  34. Ohayon, MM; McCue, M; Krystal, A; Chrones, L; Touya, M; Lawrence, D; Patel, S; Cote, ML, A Longitudinal Study to Assess Antidepressant Treatment Patterns and Outcomes in Individuals with Depression in the General Population., Cns Spectrums, vol. 26 no. 2 (April, 2021), pp. 180
  35. Scangos, KW; Makhoul, GS; Sugrue, LP; Chang, EF; Krystal, AD, State-dependent responses to intracranial brain stimulation in a patient with depression., Nat Med, vol. 27 no. 2 (February, 2021), pp. 229-231
  36. Lunsford-Avery, JR; Edinger, JD; Krystal, AD, Optimizing computation of overnight decline in delta power: Evidence for slower rate of decline in delta power in insomnia patients., Clin Neurophysiol, vol. 132 no. 2 (February, 2021), pp. 545-553
  37. Shi, G; Yin, C; Fan, Z; Xing, L; Mostovoy, Y; Kwok, P-Y; Ashbrook, LH; Krystal, AD; Ptáček, LJ; Fu, Y-H, Mutations in Metabotropic Glutamate Receptor 1 Contribute to Natural Short Sleep Trait., Curr Biol, vol. 31 no. 1 (January, 2021), pp. 13-24.e4
  38. McCall, WV; Benca, RM; Rumble, ME; Krystal, AD, Blinding and bias in a hypnotic clinical trial., Hum Psychopharmacol, vol. 36 no. 1 (January, 2021), pp. 1-5
  39. Krystal, AD; Mittoux, A; Lindsten, A; Baker, RA, Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy., J Affect Disord, vol. 278 (January, 2021), pp. 288-295
  40. Scangos, KW; Khambhati, AN; Daly, PM; Owen, LW; Manning, JR; Ambrose, JB; Austin, E; Dawes, HE; Krystal, AD; Chang, EF, Distributed Subnetworks of Depression Defined by Direct Intracranial Neurophysiology., Frontiers in Human Neuroscience, vol. 15 (2021), pp. 746499
  41. Hatch, GM; Ashbrook, L; Prather, AA; Krystal, AD, Is cellular energy monitoring more responsive to hypoxia than pulse oximetry?, Sleep Breath, vol. 24 no. 4 (December, 2020), pp. 1633-1643
  42. Dias-Barbosa, C; Matos, R; Vernon, M; Carney, CE; Krystal, A; Puelles, J, Content validity of a sleep numerical rating scale and a sleep diary in adults and adolescents with moderate-to-severe atopic dermatitis, Journal of Patient Reported Outcomes, vol. 4 no. 1 (December, 2020)
  43. Dias-Barbosa, C; Matos, R; Vernon, M; Carney, CE; Krystal, A; Puelles, J, Correction to: Content validity of a sleep numerical rating scale and a sleep diary in adults and adolescents with moderate-to-severe atopic dermatitis (Journal of Patient-Reported Outcomes, (2020), 4, 1, (100), 10.1186/s41687-020-00265-y), Journal of Patient Reported Outcomes, vol. 4 no. 1 (December, 2020)
  44. Morin, CM; Edinger, JD; Beaulieu-Bonneau, S; Ivers, H; Krystal, AD; Guay, B; Bélanger, L; Cartwright, A; Simmons, B; Lamy, M; Busby, M, Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder: A Randomized Clinical Trial., Jama Psychiatry, vol. 77 no. 11 (November, 2020), pp. 1107-1115
  45. Lunsford-Avery, JR; Keller, C; Kollins, SH; Krystal, AD; Jackson, L; Engelhard, MM, Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study., Jmir Mhealth and Uhealth, vol. 8 no. 10 (October, 2020), pp. e20590
  46. Pizzagalli, DA; Smoski, M; Ang, Y-S; Whitton, AE; Sanacora, G; Mathew, SJ; Nurnberger, J; Lisanby, SH; Iosifescu, DV; Murrough, JW; Yang, H; Weiner, RD; Calabrese, JR; Goodman, W; Potter, WZ; Krystal, AD, Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)., Neuropsychopharmacology, vol. 45 no. 10 (September, 2020), pp. 1656-1663
  47. Rumble, ME; McCall, WV; Dickson, DA; Krystal, AD; Rosenquist, PB; Benca, RM, An exploratory analysis of the association of circadian rhythm dysregulation and insomnia with suicidal ideation over the course of treatment in individuals with depression, insomnia, and suicidal ideation., J Clin Sleep Med, vol. 16 no. 8 (August, 2020), pp. 1311-1319
  48. Krystal, AD, Omitted Conflict of Interest Disclosures., Jama Psychiatry, vol. 77 no. 7 (July, 2020), pp. 768
  49. Lunsford-Avery, JR; Keller, C; Kollins, SH; Krystal, AD; Jackson, L; Engelhard, MM, Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study (Preprint) (May, 2020)
  50. Krystal, AD; Pizzagalli, DA; Smoski, M; Mathew, SJ; Nurnberger, J; Lisanby, SH; Iosifescu, D; Murrough, JW; Yang, H; Weiner, RD; Calabrese, JR; Sanacora, G; Hermes, G; Keefe, RSE; Song, A; Goodman, W; Szabo, ST; Whitton, AE; Gao, K; Potter, WZ, A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia., Nat Med, vol. 26 no. 5 (May, 2020), pp. 760-768
  51. Felder, JN; Epel, ES; Neuhaus, J; Krystal, AD; Prather, AA, Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women: A Randomized Clinical Trial., Jama Psychiatry, vol. 77 no. 5 (May, 2020), pp. 484-492
  52. Aluisio, L; Yieh, L; Wajs, E; DiBernardo, A; Krystal, A; Drevets, W; Wu, Y; Gogate, J; Daly, E; Zannikos, P; Curran, V; Chen, G; Singh, J, 142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression., Cns Spectrums, vol. 25 no. 2 (April, 2020), pp. 290
  53. Ashbrook, LH; Krystal, AD; Fu, Y-H; Ptáček, LJ, Genetics of the human circadian clock and sleep homeostat., Neuropsychopharmacology, vol. 45 no. 1 (January, 2020), pp. 45-54
  54. Krystal, AD, Sleep therapeutics and neuropsychiatric illness., Neuropsychopharmacology, vol. 45 no. 1 (January, 2020), pp. 166-175
  55. Scangos, KW; Ahmad, HS; Shafi, A; Sellers, KK; Dawes, HE; Krystal, A; Chang, EF, Pilot Study of An Intracranial Electroencephalography Biomarker of Depressive Symptoms in Epilepsy., J Neuropsychiatry Clin Neurosci, vol. 32 no. 2 (2020), pp. 185-190
  56. McCall, WV; Benca, RM; Rosenquist, PB; Youssef, NA; McCloud, L; Newman, JC; Case, D; Rumble, ME; Szabo, ST; Phillips, M; Krystal, AD, Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial., American Journal of Psychiatry, vol. 176 no. 11 (November, 2019), pp. 957-965
  57. Krystal, AD; Prather, AA; Ashbrook, LH, The assessment and management of insomnia: an update., World Psychiatry : Official Journal of the World Psychiatric Association (Wpa), vol. 18 no. 3 (October, 2019), pp. 337-352
  58. Shi, G; Xing, L; Wu, D; Bhattacharyya, BJ; Jones, CR; McMahon, T; Chong, SYC; Chen, JA; Coppola, G; Geschwind, D; Krystal, A; Ptáček, LJ; Fu, Y-H, A Rare Mutation of β1-Adrenergic Receptor Affects Sleep/Wake Behaviors., Neuron, vol. 103 no. 6 (September, 2019), pp. 1044-1055.e7
  59. Krystal, AD; Prather, AA, Sleep Pharmacogenetics: The Promise of Precision Medicine., Sleep Med Clin, vol. 14 no. 3 (September, 2019), pp. 317-331
  60. McCall, WV; Benca, RM; Rumble, ME; Case, D; Rosenquist, PB; Krystal, AD, Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder., J Psychiatr Res, vol. 116 (September, 2019), pp. 147-150
  61. Wilson, S; Anderson, K; Baldwin, D; Dijk, D-J; Espie, A; Espie, C; Gringras, P; Krystal, A; Nutt, D; Selsick, H; Sharpley, A, British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update., J Psychopharmacol, vol. 33 no. 8 (August, 2019), pp. 923-947
  62. Scangos, KW; Weiner, RD; Coffey, EC; Krystal, AD, An Electrophysiological Biomarker That May Predict Treatment Response to ECT., J Ect, vol. 35 no. 2 (June, 2019), pp. 95-102
  63. Asarnow, LD; Bei, B; Krystal, A; Buysse, DJ; Thase, ME; Edinger, JD; Manber, R, Circadian Preference as a Moderator of Depression Outcome Following Cognitive Behavioral Therapy for Insomnia Plus Antidepressant Medications: A Report From the TRIAD Study., J Clin Sleep Med, vol. 15 no. 4 (April, 2019), pp. 573-580
  64. Herring, WJ; Roth, T; Krystal, AD; Michelson, D, Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications., J Sleep Res, vol. 28 no. 2 (April, 2019), pp. e12782
  65. Strollo, PJ; Hedner, J; Collop, N; Lorch, DG; Chen, D; Carter, LP; Lu, Y; Lee, L; Black, J; Pépin, J-L; Redline, S; Tones 4 Study Investigators,, Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study., Chest, vol. 155 no. 2 (February, 2019), pp. 364-374
  66. Ohayon, MM; Black, J; Krystal, AD; Shapiro, CM; Swick, TJ; Bogan, R; Wells, CC, Longitudinal study of narcolepsy symptoms in first, second, and third-degree relatives of simplex and multiplex narcolepsy families., Sleep Med, vol. 53 (January, 2019), pp. 88-93
  67. La, AL; Walsh, CM; Neylan, TC; Vossel, KA; Yaffe, K; Krystal, AD; Miller, BL; Karageorgiou, E, Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers., J Alzheimers Dis, vol. 67 no. 3 (2019), pp. 911-921
  68. Krystal, AD; Pizzagalli, DA; Mathew, SJ; Sanacora, G; Keefe, R; Song, A; Calabrese, J; Goddard, A; Goodman, W; Lisanby, SH; Smoski, M; Weiner, R; Iosifescu, D; Nurnberger, J; Szabo, S; Murrough, J; Shekhar, A; Potter, W, The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development., Nat Rev Drug Discov, vol. 18 no. 1 (December, 2018), pp. 82-84
  69. Dominguez, JE; Habib, AS; Krystal, AD, A review of the associations between obstructive sleep apnea and hypertensive disorders of pregnancy and possible mechanisms of disease., Sleep Med Rev, vol. 42 (December, 2018), pp. 37-46
  70. Dominguez, JE; Grotegut, CA; Cooter, M; Krystal, AD; Habib, AS, Screening extremely obese pregnant women for obstructive sleep apnea., American Journal of Obstetrics and Gynecology, vol. 219 no. 6 (December, 2018), pp. 613.e1-613.e10
  71. Szabo, ST; Kandra, K; Krystal, AD, Effect of γ-hydroxybutyrate (Xyrem) on locus coeruleus activity as measured by pupillometry in a patient with narcolepsy., International Journal of Clinical Pharmacology and Therapeutics, vol. 56 no. 12 (December, 2018), pp. 620-622
  72. Dominguez, JE; Krystal, AD; Habib, AS, Obstructive Sleep Apnea in Pregnant Women: A Review of Pregnancy Outcomes and an Approach to Management., Anesth Analg, vol. 127 no. 5 (November, 2018), pp. 1167-1177
  73. Lundeen, J; McCall, WV; Krystal, A; Looney, S, Validating functional data analysis measures from 24-h actigraphy data, Biological Rhythm Research, vol. 49 no. 5 (September, 2018), pp. 797-810, Informa UK Limited
  74. Beppler, EC; Dieffenderfer, J; Songkakul, T; Krystal, A; Bozkurt, A, An Ultra-miniaturized Near Infrared Spectroscopy System to Assess Sleep Apnea in Children with Down Syndrome., Annu Int Conf Ieee Eng Med Biol Soc, vol. 2018 (July, 2018), pp. 2877-2880
  75. Bei, B; Asarnow, LD; Krystal, A; Edinger, JD; Buysse, DJ; Manber, R, Treating insomnia in depression: Insomnia related factors predict long-term depression trajectories., J Consult Clin Psychol, vol. 86 no. 3 (March, 2018), pp. 282-293, American Psychological Association (APA)
  76. Rumble, ME; Dickson, D; McCall, WV; Krystal, AD; Case, D; Rosenquist, PB; Benca, RM, The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review., J Affect Disord, vol. 227 (February, 2018), pp. 721-730
  77. Valero-Sarmiento, JM; Reynolds, J; Krystal, A; Bozkurt, A, In vitro evaluation of an injectable EEG/ECG sensor for wireless monitoring of hibernation in endangered animal species, Ieee Sensors Journal, vol. 18 no. 2 (January, 2018), pp. 798-808, Institute of Electrical and Electronics Engineers (IEEE)
  78. Loo, CK; Husain, MM; McDonald, WM; Aaronson, S; O'Reardon, JP; Alonzo, A; Weickert, CS; Martin, DM; McClintock, SM; Mohan, A; Lisanby, SH; International Consortium of Research in tDCS (ICRT),, International randomized-controlled trial of transcranial Direct Current Stimulation in depression., Brain Stimul, vol. 11 no. 1 (2018), pp. 125-133
  79. McClintock, SM; Reti, IM; Carpenter, LL; McDonald, WM; Dubin, M; Taylor, SF; Cook, IA; O'Reardon, J; Husain, MM; Wall, C; Krystal, A; Sampson, S; Morales, O; Nelson, BG; George, MS; Lisanby, SH, Dr McClintock and Colleagues Reply., The Journal of Clinical Psychiatry, vol. 79 no. 1 (2018)
  80. McClintock, SM; Reti, IM; Carpenter, LL; McDonald, WM; Dubin, M; Taylor, SF; Cook, IA; O'Reardon, J; Husain, MM; Wall, C; Krystal, AD; Sampson, SM; Morales, O; Nelson, BG; Latoussakis, V; George, MS; Lisanby, SH; National Network of Depression Centers rTMS Task Group, ; American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments,, Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression., The Journal of Clinical Psychiatry, vol. 79 no. 1 (2018)
  81. Goucher Miranda, H; Krystal, AD; Fierro, MA, Nocturnal Dexmedetomidine in Nonintubated, Critically Ill Patients: Sleep or Sedation?, Anesthesiology, vol. 127 no. 2 (August, 2017), pp. 397-398
  82. Connor, KM; Ceesay, P; Hutzelmann, J; Snavely, D; Krystal, AD; Trivedi, MH; Thase, M; Lines, C; Herring, WJ; Michelson, D, Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder., The International Journal of Neuropsychopharmacology, vol. 20 no. 8 (August, 2017), pp. 613-618
  83. Evans, JL; Nadler, JW; Preud'homme, XA; Fang, E; Daughtry, RL; Chapman, JB; Attarian, D; Wellman, S; Krystal, AD, Pilot prospective study of post-surgery sleep and EEG predictors of post-operative delirium., Clin Neurophysiol, vol. 128 no. 8 (August, 2017), pp. 1421-1425
  84. Samson, DR; Manus, MB; Krystal, AD; Fakir, E; Yu, JJ; Nunn, CL, Segmented sleep in a nonelectric, small-scale agricultural society in Madagascar., Am J Hum Biol, vol. 29 no. 4 (July, 2017)
  85. Herring, WJ; Connor, KM; Snyder, E; Snavely, DB; Zhang, Y; Hutzelmann, J; Matzura-Wolfe, D; Benca, RM; Krystal, AD; Walsh, JK; Lines, C; Roth, T; Michelson, D, Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials., Am J Geriatr Psychiatry, vol. 25 no. 7 (July, 2017), pp. 791-802
  86. Sateia, MJ; Buysse, DJ; Krystal, AD; Neubauer, DN, Adverse Effects of Hypnotic Medications., J Clin Sleep Med, vol. 13 no. 6 (June, 2017), pp. 839
  87. Herring, WJ; Connor, KM; Snyder, E; Snavely, DB; Zhang, Y; Hutzelmann, J; Matzura-Wolfe, D; Benca, RM; Krystal, AD; Walsh, JK; Lines, C; Roth, T; Michelson, D, Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data., Psychopharmacology (Berl), vol. 234 no. 11 (June, 2017), pp. 1703-1711
  88. Nadler, JW; Evans, JL; Fang, E; Preud'Homme, XA; Daughtry, RL; Chapman, JB; Bolognesi, MP; Attarian, DE; Wellman, SS; Krystal, AD, A randomised trial of peri-operative positive airway pressure for postoperative delirium in patients at risk for obstructive sleep apnoea after regional anaesthesia with sedation or general anaesthesia for joint arthroplasty., Anaesthesia, vol. 72 no. 6 (June, 2017), pp. 729-736
  89. Carney, CE; Edinger, JD; Kuchibhatla, M; Lachowski, AM; Bogouslavsky, O; Krystal, AD; Shapiro, CM, Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial., Sleep, vol. 40 no. 4 (April, 2017)
  90. Edinger, JD; Manber, R; Buysse, DJ; Krystal, AD; Thase, ME; Gehrman, P; Fairholme, CP; Luther, J; Wisniewski, S, Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study., J Clin Sleep Med, vol. 13 no. 2 (February, 2017), pp. 205-213
  91. Sateia, MJ; Buysse, DJ; Krystal, AD; Neubauer, DN; Heald, JL, Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline., J Clin Sleep Med, vol. 13 no. 2 (February, 2017), pp. 307-349
  92. Ohayon, M; Wickwire, EM; Hirshkowitz, M; Albert, SM; Avidan, A; Daly, FJ; Dauvilliers, Y; Ferri, R; Fung, C; Gozal, D; Hazen, N; Krystal, A; Lichstein, K; Mallampalli, M; Plazzi, G; Rawding, R; Scheer, FA; Somers, V; Vitiello, MV, National Sleep Foundation's sleep quality recommendations: first report., Sleep Health, vol. 3 no. 1 (February, 2017), pp. 6-19
  93. Krystal, AD; Prather, AA, Should Internet Cognitive Behavioral Therapy for Insomnia Be the Primary Treatment Option for Insomnia?: Toward Getting More SHUTi., Jama Psychiatry, vol. 74 no. 1 (January, 2017), pp. 15-16
  94. McCall, WV; Benca, RM; Rosenquist, PB; Riley, MA; McCloud, L; Newman, JC; Case, D; Rumble, M; Krystal, AD, Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA., American Journal of Psychiatry, vol. 174 no. 1 (January, 2017), pp. 18-25
  95. Bathgate, CJ; Edinger, JD; Krystal, AD, Insomnia Patients With Objective Short Sleep Duration Have a Blunted Response to Cognitive Behavioral Therapy for Insomnia., Sleep, vol. 40 no. 1 (January, 2017)
  96. Krystal, AD; Preud'homme, XA, Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia., Sleep, vol. 40 no. 1 (January, 2017)
  97. Lunsford-Avery, JR; Krystal, AD; Kollins, SH, Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research., Clin Psychol Rev, vol. 50 (December, 2016), pp. 159-174
  98. Ptáǒek, LJ; Fu, Y-H; Krystal, AD, Sleep and Mood: Chicken or Egg?, Biol Psychiatry, vol. 80 no. 11 (December, 2016), pp. 810-811
  99. Krystal, A; Attarian, H, Sleep Medications and Women: a Review of Issues to Consider for Optimizing the Care of Women with Sleep Disorders, Current Sleep Medicine Reports, vol. 2 no. 4 (December, 2016), pp. 218-222
  100. Jacobsen, JPR; Krystal, AD; Krishnan, KRR; Caron, MG, Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale., Trends Pharmacol Sci, vol. 37 no. 11 (November, 2016), pp. 933-944
  101. Carlezon, WA; Krystal, AD, Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials., Depress Anxiety, vol. 33 no. 10 (October, 2016), pp. 895-906
  102. Herring, WJ; Connor, KM; Snyder, E; Snavely, DB; Zhang, Y; Hutzelmann, J; Matzura-Wolfe, D; Benca, RM; Krystal, AD; Walsh, JK; Lines, C; Roth, T; Michelson, D, Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials., J Clin Sleep Med, vol. 12 no. 9 (September, 2016), pp. 1215-1225
  103. Bathgate, CJ; Edinger, JD; Krystal, AD, Insomnia Patients with Objective Short Sleep Duration have a Blunted Response to Cognitive Behavioral Therapy for Insomnia., Sleep (September, 2016)
  104. Krystal, AD; Preud'homme, XA, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER, STUDY OF ARMODAFINIL TREATMENT OF DAYTIME SLEEPINESS ASSOCIATED WITH TREATED NOCTURIA., Sleep (September, 2016)
  105. Krystal, AD; Mittoux, A; Meisels, P; Baker, RA, Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study., Prim Care Companion Cns Disord, vol. 18 no. 5 (September, 2016)
  106. Blanco, MB; Dausmann, KH; Faherty, SL; Klopfer, P; Krystal, AD; Schopler, R; Yoder, AD, Hibernation in a primate: does sleep occur?, Royal Society Open Science, vol. 3 no. 8 (August, 2016), pp. 160282
  107. Krystal, JH; Abi-Dargham, A; Akbarian, S; Arnsten, AFT; Barch, DM; Bearden, CE; Braff, DL; Brown, ES; Bullmore, ET; Carlezon, WA; Carter, CS; Cook, EH; Daskalakis, ZJ; DiLeone, RJ; Duman, RS; Grace, AA; Hariri, AR; Harrison, PJ; Hiroi, N; Kenny, PJ; Kleinman, JE; Krystal, AD; Lewis, DA; Lipska, BK; Marder, SR; Mason, GF; Mathalon, DH; McClung, CA; McDougle, CJ; McIntosh, AM; McMahon, FJ; Mirnics, K; Monteggia, LM; Narendran, R; Nestler, EJ; Neumeister, A; O'Donovan, MC; Öngür, D; Pariante, CM; Paulus, MP; Pearlson, G; Phillips, ML; Pine, DS; Pizzagalli, DA; Pletnikov, MV; Ragland, JD; Rapoport, JL; Ressler, KJ; Russo, SJ; Sanacora, G; Sawa, A; Schatzberg, AF; Shaham, Y; Shamay-Tsoory, SG; Sklar, P; State, MW; Stein, MB; Strakowski, SM; Taylor, SF; Turecki, G; Turetsky, BI; Weissman, MM; Zachariou, V; Zarate, CA; Zubieta, J-K, Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research., Biol Psychiatry, vol. 80 no. 2 (July, 2016), pp. 84-86
  108. Bathgate, CJ; Edinger, JD; Wyatt, JK; Krystal, AD, Objective but Not Subjective Short Sleep Duration Associated with Increased Risk for Hypertension in Individuals with Insomnia., Sleep, vol. 39 no. 5 (May, 2016), pp. 1037-1045
  109. Krystal, AD; Zammit, G, The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia., Hum Psychopharmacol, vol. 31 no. 3 (May, 2016), pp. 206-216
  110. Krystal, JH; Pietrzak, RH; Rosenheck, RA; Cramer, JA; Vessicchio, J; Jones, KM; Huang, GD; Vertrees, JE; Collins, J; Krystal, AD; Veterans Affairs Cooperative Study #504 Group,, Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504., The Journal of Clinical Psychiatry, vol. 77 no. 4 (April, 2016), pp. 483-491, ISSN 0160-6689
  111. Krystal, AD; Sorscher, AJ, Recognizing and managing insomnia in primary care and specialty settings., The Journal of Clinical Psychiatry, vol. 77 no. 4 (April, 2016), pp. e471
  112. Morin, CM; Edinger, JD; Krystal, AD; Buysse, DJ; Beaulieu-Bonneau, S; Ivers, H, Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial., Trials, vol. 17 no. 1 (March, 2016), pp. 118
  113. Herring, WJ; Connor, KM; Ivgy-May, N; Snyder, E; Liu, K; Snavely, DB; Krystal, AD; Walsh, JK; Benca, RM; Rosenberg, R; Sangal, RB; Budd, K; Hutzelmann, J; Leibensperger, H; Froman, S; Lines, C; Roth, T; Michelson, D, Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials., Biol Psychiatry, vol. 79 no. 2 (January, 2016), pp. 136-148, ISSN 0006-3223
  114. Nunn, CL; Samson, DR; Krystal, AD, Shining evolutionary light on human sleep and sleep disorders., Evolution, Medicine, and Public Health, vol. 2016 no. 1 (2016), pp. 227-243
  115. Krystal, AD, New Developments in Insomnia Medications of Relevance to Mental Health Disorders., Psychiatr Clin North Am, vol. 38 no. 4 (December, 2015), pp. 843-860, ISSN 0193-953X
  116. Morin, CM; Drake, CL; Harvey, AG; Krystal, AD; Manber, R; Riemann, D; Spiegelhalder, K, Insomnia disorder., Nature Reviews. Disease Primers, vol. 1 (September, 2015), pp. 15026
  117. Peterchev, AV; Krystal, AD; Rosa, MA; Lisanby, SH, Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy., Neuropsychopharmacology, vol. 40 no. 9 (August, 2015), pp. 2076-2084, ISSN 0893-133X
  118. Krystal, AD, Current, emerging, and newly available insomnia medications., The Journal of Clinical Psychiatry, vol. 76 no. 8 (August, 2015), pp. e1045, ISSN 0160-6689
  119. Ivgy-May, N; Ruwe, F; Krystal, A; Roth, T, Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial., Sleep Med, vol. 16 no. 7 (July, 2015), pp. 838-844, ISSN 1389-9457
  120. Krystal, JH; Stossel, S; Krystal, AD, Restricting Benzodiazepines to Short-Term Prescription., Jama Psychiatry, vol. 72 no. 7 (July, 2015), pp. 734-735, ISSN 2168-622X
  121. McCall, WV; Benca, RM; Rosenquist, PB; Riley, MA; Hodges, C; Gubosh, B; McCloud, L; Newman, JC; Case, D; Rumble, M; Mayo, M; White, KH; Phillips, M; Krystal, AD, A multi-site randomized clinical trial to reduce suicidal ideation in suicidal adult outpatients with Major Depressive Disorder: Development of a methodology to enhance safety., Clin Trials, vol. 12 no. 3 (June, 2015), pp. 189-198, ISSN 1740-7745
  122. Szabo, ST; Kinon, BJ; Brannan, SK; Krystal, AK; van Gerven, JMA; Mahableshwarkar, A; Sachs, GS, Lessons learned and potentials for improvement in cns drug development: Isctm section on designing the right series of experiments, Innovations in Clinical Neuroscience, vol. 12 no. 3-4 (March, 2015), pp. 11S-25S
  123. Rapp, PE; Keyser, DO; Albano, A; Hernandez, R; Gibson, DB; Zambon, RA; David Hairston, W; Hughes, JD; Krystal, A; Nichols, AS, Traumatic brain injury detection using electrophysiological methods, Frontiers in Human Neuroscience, vol. 9 no. FEB (February, 2015), FRONTIERS MEDIA SA
  124. Leuchter, AF; Cook, IA; Feifel, D; Goethe, JW; Husain, M; Carpenter, LL; Thase, ME; Krystal, AD; Philip, NS; Bhati, MT; Burke, WJ; Howland, RH; Sheline, YI; Aaronson, ST; Iosifescu, DV; O'Reardon, JP; Gilmer, WS; Jain, R; Burgoyne, KS; Phillips, B; Manberg, PJ; Massaro, J; Hunter, AM; Lisanby, SH; George, MS, Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression., Brain Stimul, vol. 8 no. 4 (2015), pp. 787-794, ISSN 1935-861X
  125. Tek, C; Palmese, LB; Krystal, AD; Srihari, VH; DeGeorge, PC; Reutenauer, EL; Guloksuz, S, The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial., Schizophrenia Research, vol. 160 no. 1-3 (December, 2014), pp. 180-185, ISSN 0920-9964
  126. Calabrese, JR; Fava, M; Garibaldi, G; Grunze, H; Krystal, AD; Laughren, T; Macfadden, W; Marin, R; Nierenberg, AA; Tohen, M, Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders., J Affect Disord, vol. 168 (October, 2014), pp. 439-451, ISSN 0165-0327
  127. Goforth, HW; Preud'homme, XA; Krystal, AD, A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain., Sleep, vol. 37 no. 6 (June, 2014), pp. 1053-1060, ISSN 0161-8105
  128. McClintock, SM; Choi, J; Deng, Z-D; Appelbaum, LG; Krystal, AD; Lisanby, SH, Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy., J Ect, vol. 30 no. 2 (June, 2014), pp. 165-176, ISSN 1095-0680
  129. Michelson, D; Snyder, E; Paradis, E; Chengan-Liu, M; Snavely, DB; Hutzelmann, J; Walsh, JK; Krystal, AD; Benca, RM; Cohn, M; Lines, C; Roth, T; Herring, WJ, Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial., Lancet Neurol, vol. 13 no. 5 (May, 2014), pp. 461-471, ISSN 1474-4422
  130. Krystal, AD; Zhang, W; Davidson, JRT; Connor, KM, The sleep effects of tiagabine on the first night of treatment predict post-traumatic stress disorder response at three weeks., J Psychopharmacol, vol. 28 no. 5 (May, 2014), pp. 457-465
  131. Mirrakhimov, AE; Brewbaker, CL; Krystal, AD; Kwatra, MM, Obstructive sleep apnea and delirium: exploring possible mechanisms., Sleep Breath, vol. 18 no. 1 (March, 2014), pp. 19-29
  132. Greve, DN; Duntley, SP; Larson-Prior, L; Krystal, AD; Diaz, MT; Drummond, SPA; Thein, SG; Kushida, CA; Yang, R; Thomas, RJ, Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study., J Clin Sleep Med, vol. 10 no. 2 (February, 2014), pp. 143-153, ISSN 1550-9389
  133. Wang, X; Bey, AL; Chung, L; Krystal, AD; Jiang, Y-H, Therapeutic approaches for shankopathies., Dev Neurobiol, vol. 74 no. 2 (February, 2014), pp. 123-135
  134. Low, Y; Goforth, H; Preud'homme, X; Edinger, J; Krystal, A, Insomnia in HIV-infected patients: pathophysiologic implications., Aids Rev, vol. 16 no. 1 (2014), pp. 3-13, ISSN 1139-6121
  135. Minkel, J; Krystal, AD, Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons., Sleep Med Clin, vol. 8 no. 3 (September, 2013), pp. 333-350, ISSN 1556-407X
  136. Edinger, JD; Means, MK; Krystal, AD, Does physiological hyperarousal enhance error rates among insomnia sufferers?, Sleep, vol. 36 no. 8 (August, 2013), pp. 1179-1186
  137. Krystal, AD; Richelson, E; Roth, T, Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications., Sleep Med Rev, vol. 17 no. 4 (August, 2013), pp. 263-272
  138. Preud'homme, XA; Amundsen, CL; Webster, GD; Krystal, AD, Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls., Int Urogynecol J, vol. 24 no. 3 (March, 2013), pp. 501-508
  139. Roth, T; Krystal, A; Steinberg, FJ; Singh, NN; Moline, M, Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study., Sleep, vol. 36 no. 2 (February, 2013), pp. 189-196, ISSN 0161-8105
  140. Rosenquist, PB; Krystal, A; Heart, KL; Demitrack, MA; McCall, WV, Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder., Psychiatry Research, vol. 205 no. 1-2 (January, 2013), pp. 67-73, ISSN 0165-1781
  141. Krystal, AD; Benca, RM; Kilduff, TS, Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system., The Journal of Clinical Psychiatry, vol. 74 Suppl 1 (2013), pp. 3-20
  142. Krystal, AD; Schopler, B; Kobbe, S; Williams, C; Rakatondrainibe, H; Yoder, AD; Klopfer, P, The relationship of sleep with temperature and metabolic rate in a hibernating primate., Plos One, vol. 8 no. 9 (2013), pp. e69914
  143. Krystal, AD, Sleep in Mood Disorders (December, 2012), pp. 675-681, Elsevier
  144. Low, Y; Goforth, HW; Omonuwa, T; Preud'homme, X; Edinger, J; Krystal, A, Comparison of polysomnographic data in age-, sex- and Axis I psychiatric diagnosis matched HIV-seropositive and HIV-seronegative insomnia patients., Clin Neurophysiol, vol. 123 no. 12 (December, 2012), pp. 2402-2405, ISSN 1388-2457
  145. Krystal, AD, Psychiatric disorders and sleep., Neurol Clin, vol. 30 no. 4 (November, 2012), pp. 1389-1413
  146. Krystal, AD; Roth, T; Simon, RD, Shift work disorder case studies: applying management principles in clinical practice., The Journal of Clinical Psychiatry, vol. 73 no. 8 (August, 2012), pp. e25
  147. Krystal, AD; Huang, H; Zummo, J; Grinnell, T; Marshall, RD, A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg., Sleep Med, vol. 13 no. 6 (June, 2012), pp. 691-696
  148. Ohayon, MM; Mahowald, MW; Dauvilliers, Y; Krystal, AD; Léger, D, Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population., Neurology, vol. 78 no. 20 (May, 2012), pp. 1583-1589
  149. Flink, BJ; Rivelli, SK; Cox, EA; White, WD; Falcone, G; Vail, TP; Young, CC; Bolognesi, MP; Krystal, AD; Trzepacz, PT; Moon, RE; Kwatra, MM, Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly., Anesthesiology, vol. 116 no. 4 (April, 2012), pp. 788-796
  150. Carney, CE; Buysse, DJ; Ancoli-Israel, S; Edinger, JD; Krystal, AD; Lichstein, KL; Morin, CM, The consensus sleep diary: standardizing prospective sleep self-monitoring., Sleep, vol. 35 no. 2 (February, 2012), pp. 287-302
  151. Krystal, AD, How the circadian rhythm affects sleep, wakefulness, and overall health: background for understanding shift work disorder., The Journal of Clinical Psychiatry, vol. 73 no. 2 (February, 2012), pp. e05
  152. Ulmer, CS; Sutherland, M; Edinger, JD; Davidson, J; Connor, KM; Zhang, W; Krystal, A, REM sleep bout duration and frequency in PTSD, Journal of Aggression, Maltreatment & Trauma, vol. 21 no. 1 (January, 2012), pp. 67-76, Informa UK Limited, ISSN 1092-6771
  153. Krystal, AD; McCall, WV; Fava, M; Joffe, H; Soares, CN; Huang, H; Grinell, T; Zummo, J; Spalding, W; Marshall, R, Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity., The Primary Care Companion for Cns Disorders, vol. 14 no. 4 (2012), ISSN 2155-7772
  154. Krystal, AD; Sutherland, J; Hochman, DW, Loop diuretics have anxiolytic effects in rat models of conditioned anxiety., Plos One, vol. 7 no. 4 (2012), pp. e35417
  155. Low, Y; Preud'homme, X; Goforth, HW; Omonuwa, T; Krystal, AD, The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study., Sleep, vol. 34 no. 12 (December, 2011), pp. 1723-1726
  156. Palmese, LB; DeGeorge, PC; Ratliff, JC; Srihari, VH; Wexler, BE; Krystal, AD; Tek, C, Insomnia is frequent in schizophrenia and associated with night eating and obesity., Schizophrenia Research, vol. 133 no. 1-3 (December, 2011), pp. 238-243
  157. Rose, JE; McClernon, FJ; Froeliger, B; Behm, FM; Preud'homme, X; Krystal, AD, Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes., Biol Psychiatry, vol. 70 no. 8 (October, 2011), pp. 794-799
  158. Krystal, AD; Lankford, A; Durrence, HH; Ludington, E; Jochelson, P; Rogowski, R; Roth, T, Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia., Sleep, vol. 34 no. 10 (October, 2011), pp. 1433-1442
  159. Edinger, JD; Wyatt, JK; Stepanski, EJ; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Crisostomo, MI; Lineberger, MD; Means, MK; Radtke, RA; Wohlgemuth, WK; Krystal, AD, Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis., Arch Gen Psychiatry, vol. 68 no. 10 (October, 2011), pp. 992-1002
  160. Carney, CE; Moss, TG; Harris, AL; Edinger, JD; Krystal, AD, Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients?, J Psychiatr Res, vol. 45 no. 9 (September, 2011), pp. 1243-1249
  161. Krystal, AD, A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression (Journal of Clinical Psychiatry (2010) 71, 1 (32-40)), The Journal of Clinical Psychiatry, vol. 72 no. 8 (August, 2011), pp. 1157, ISSN 0160-6689
  162. Krystal, AD, Recognition and assessment of shift work disorder., The Journal of Clinical Psychiatry, vol. 72 no. 2 (February, 2011), pp. 248-257, Physicians Postgraduate Press, Inc, ISSN 0160-6689
  163. Richey, SM; Krystal, AD, Pharmacological advances in the treatment of insomnia., Curr Pharm Des, vol. 17 no. 15 (2011), pp. 1471-1475
  164. Krystal, AD, Antidepressant and Antipsychotic Drugs., Sleep Med Clin, vol. 5 no. 4 (December, 2010), pp. 571-589, ISSN 1556-407X
  165. Krystal, AD; Durrence, HH; Scharf, M; Jochelson, P; Rogowski, R; Ludington, E; Roth, T, Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia., Sleep, vol. 33 no. 11 (November, 2010), pp. 1553-1561, ISSN 0161-8105
  166. Wilson, SJ; Nutt, DJ; Alford, C; Argyropoulos, SV; Baldwin, DS; Bateson, AN; Britton, TC; Crowe, C; Dijk, D-J; Espie, CA; Gringras, P; Hajak, G; Idzikowski, C; Krystal, AD; Nash, JR; Selsick, H; Sharpley, AL; Wade, AG, British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders., J Psychopharmacol, vol. 24 no. 11 (November, 2010), pp. 1577-1601
  167. Janicak, PG; Nahas, Z; Lisanby, SH; Solvason, HB; Sampson, SM; McDonald, WM; Marangell, LB; Rosenquist, P; McCall, WV; Kimball, J; O'Reardon, JP; Loo, C; Husain, MH; Krystal, A; Gilmer, W; Dowd, SM; Demitrack, MA; Schatzberg, AF, Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study., Brain Stimul, vol. 3 no. 4 (October, 2010), pp. 187-199, ISSN 1935-861X
  168. Flynn, KE; Shelby, RA; Mitchell, SA; Fawzy, MR; Hardy, NC; Husain, AM; Keefe, FJ; Krystal, AD; Porter, LS; Reeve, BB; Weinfurt, KP, Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®))., Psychooncology, vol. 19 no. 10 (October, 2010), pp. 1086-1093
  169. McCall, WV; Blocker, JN; D'Agostino, R; Kimball, J; Boggs, N; Lasater, B; Haskett, R; Krystal, A; McDonald, WM; Rosenquist, PB, Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 6 no. 4 (August, 2010), pp. 322-329, ISSN 1550-9389
  170. Krystal, AD; Zammit, GK; Wyatt, JK; Quan, SF; Edinger, JD; White, DP; Chiacchierini, RP; Malhotra, A, The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 6 no. 4 (August, 2010), pp. 315-321, ISSN 1550-9389
  171. Krystal, AD; Preud'homme, XA; Amundsen, CL; Webster, GD, Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study., The Journal of Urology, vol. 184 no. 2 (August, 2010), pp. 623-628
  172. Krystal, AD, In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications., Sleep, vol. 33 no. 7 (July, 2010), pp. 859-860, ISSN 0161-8105
  173. Krystal, AD; Edinger, JD, Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia., Sleep, vol. 33 no. 5 (May, 2010), pp. 669-677, ISSN 0161-8105
  174. Ohayon, MM; Krystal, A; Roehrs, TA; Roth, T; Vitiello, MV, Using difficulty resuming sleep to define nocturnal awakenings., Sleep Med, vol. 11 no. 3 (March, 2010), pp. 236-241, ISSN 1389-9457
  175. Ancoli-Israel, S; Krystal, AD; McCall, WV; Schaefer, K; Wilson, A; Claus, R; Rubens, R; Roth, T, A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia., Sleep, vol. 33 no. 2 (February, 2010), pp. 225-234, ISSN 0161-8105
  176. Krystal, AD; Harsh, JR; Yang, R; Rippon, GA; Lankford, DA, A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression., The Journal of Clinical Psychiatry, vol. 71 no. 1 (January, 2010), pp. 32-40
  177. Ancoli-Lsrael, S; Krystal, AD, Insomnia: A health care (gap that is growing), Psychiatric Times, vol. 27 no. SUPPL. APRIL (January, 2010), pp. 1-4, ISSN 0893-2905
  178. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, AA; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, UTILITY, VALIDITY, AND METHODOLOGICAL FACTORS INFLUENCING ASSIGNMENT OF DSM-IV-TR INSOMNIA DIAGNOSES: CONSIDERATIONS FOR DSM-V, Sleep, vol. 33 (January, 2010), pp. A191-A191, OXFORD UNIV PRESS INC, ISSN 0161-8105
  179. Edinger, JD; Green, MR; Prather, AA; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, AA; Krystal, AD; Radtke, RA, VALIDITY AND RELIABILITY OF THE DSM-IV-TR AND ICSD-2 INSOMNIA NOSOLOGIES AMONG CAUCASIANS AND AFRICAN-AMERICANS, Sleep, vol. 33 (January, 2010), pp. A209-A209, OXFORD UNIV PRESS INC, ISSN 0161-8105
  180. Preud'homme, XA; Amundsen, CL; Webster, GD; Krystal, AD, MONITORED NIGHTTIME BLADDER FUNCTION: COMPARISONS BETWEEN PATIENTS WITH INSOMNIA AND THOSE WITH OVERACTIVE BLADDER SYNDROME, Sleep, vol. 33 (January, 2010), pp. A293-A293, OXFORD UNIV PRESS INC, ISSN 0161-8105
  181. Preud'homme, XA; Amundsen, CL; Webster, GD; Krystal, AD, SELF-REPORTED SLEEP: HOW DO PATIENTS WITH OAB COMPARE TO INSOMNIACS AND NORMAL SUBJECTS?, Sleep, vol. 33 (January, 2010), pp. A292-A292, OXFORD UNIV PRESS INC, ISSN 0161-8105
  182. Krystal, AD; Preud'homme, XA; Amundsen, CL; Webster, GD, NOCTURNAL DETRUSOR OVERACTIVITY IN OVERACTIVE BLADDER SYNDROME: A NOCTURNAL CYSTOMETROGRAPHIC AND POLYSOMNOGRAPHIC STUDY, Sleep, vol. 33 (January, 2010), pp. A293-A293, OXFORD UNIV PRESS INC, ISSN 0161-8105
  183. Krystal, AD; Harsh, J; Yang, R; Rippon, GA; Lankford, A, EFFECT OF ARMODAFINIL ON PATIENT FUNCTIONING AND FATIGUE: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY IN PATIENTS WITH RESIDUAL EXCESSIVE SLEEPINESS ASSOCIATED WITH TREATED OBSTRUCTIVE SLEEP APNEA AND A COMORBID DEPRESSIVE DISORDER, Sleep, vol. 33 (January, 2010), pp. A7-A8, OXFORD UNIV PRESS INC, ISSN 0161-8105
  184. Low, Y; Omonuwa, T; Goforth, HW; Krystal, AD, INSOMNIA SEVERITY IN HIV-SEROPOSITIVE PATIENTS IS ASSOCIATED WITH INCREASED FATIGUE, Sleep, vol. 33 (January, 2010), pp. A194-A194, OXFORD UNIV PRESS INC, ISSN 0161-8105
  185. Low, Y; Suarez, EC; Omonuwa, T; Goforth, HW; Krystal, AD, A PILOT STUDY: IMPROVEMENT IN INSOMNIA SEVERITY IS ASSOCIATED WITH DECREASED SOLUBLE CD4-LIGAND IN HIV-SEROPOSITIVE PATIENTS, Sleep, vol. 33 (January, 2010), pp. A26-A27, OXFORD UNIV PRESS INC, ISSN 0161-8105
  186. Krystal, AD, The treatment of primary insomnia., Cns Spectrums, vol. 14 no. 12 Suppl 13 (December, 2009), pp. 6-10, ISSN 1092-8529
  187. Krystal, AD, A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice., Sleep Med Rev, vol. 13 no. 4 (August, 2009), pp. 265-274
  188. Omonuwa, TS; Goforth, HW; Preud'homme, X; Krystal, AD, The pharmacologic management of insomnia in patients with HIV., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 5 no. 3 (June, 2009), pp. 251-262, ISSN 1550-9389
  189. Carney, CE; Ulmer, C; Edinger, JD; Krystal, AD; Knauss, F, Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II)., Journal of Psychiatric Research, vol. 43 no. 5 (February, 2009), pp. 576-582, ISSN 0022-3956
  190. Lisanby, SH; Husain, MM; Rosenquist, PB; Maixner, D; Gutierrez, R; Krystal, A; Gilmer, W; Marangell, LB; Aaronson, S; Daskalakis, ZJ; Canterbury, R; Richelson, E; Sackeim, HA; George, MS, Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial., Neuropsychopharmacology, vol. 34 no. 2 (January, 2009), pp. 522-534
  191. Carney, CE; Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Chiang, A; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, SHOULD DSM-IV-TR PRIMARY INSOMNIA BE DIVIDED INTO SPECIFIC SUBTYPES?, Sleep, vol. 32 (January, 2009), pp. A264-A265, OXFORD UNIV PRESS INC, ISSN 0161-8105
  192. Sutherland, ME; Edinger, JD; Carney, C; Preud'homme, X; Krystal, AD, EFFECTS OF MANUAL ARTIFACT-REJECTION ON NON-REM SLEEP EEG SPECTRAL ANALYSIS, Sleep, vol. 32 (January, 2009), pp. A374-A374, OXFORD UNIV PRESS INC, ISSN 0161-8105
  193. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, RELIABILITY AND VALIDITY OF THE DUKE STRUCTURED INTERVIEW FOR SLEEP DISORDERS FOR INSOMNIA SCREENING, Sleep, vol. 32 (January, 2009), pp. A265-A265, OXFORD UNIV PRESS INC, ISSN 0161-8105
  194. Kane, JM; Krystal, AD; McKenzie, JE; Yang, R; Tiller, J; Youakim, JM, SLEEP IN SCHIZOPHRENIA: A NIGHT- AND DAYTIME ACTIGRAPHY STUDY IN PATIENTS WITH TREATED WITH ORAL RISPERIDONE, OLANZAPINE OR PALIPERIDONE, Sleep, vol. 32 (January, 2009), pp. A355-A355, OXFORD UNIV PRESS INC, ISSN 0161-8105
  195. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, COMPARATIVE VALIDITY OF THE DSM-IV-TR AND ICSD-2 INSOMNIA NOSOLOGIES: HOW MANY WAYS SHOULD WE SLICE THE INSOMNIA PIE?, Sleep, vol. 32 (January, 2009), pp. A263-A263, OXFORD UNIV PRESS INC, ISSN 0161-8105
  196. Preud'homme, XA; Lanquart, J-P; Krystal, AD; Bogaerts, P; Linkowski, P, Modeling slow-wave activity dynamics: does an exponentially dampened periodic function really fit a single night of normal human sleep?, Clin Neurophysiol, vol. 119 no. 12 (December, 2008), pp. 2753-2761
  197. Krystal, AD; Edinger, JD, Measuring sleep quality., Sleep Med, vol. 9 Suppl 1 (September, 2008), pp. S10-S17
  198. Krystal, AD, Non-REM sleep EEG spectral analysis in insomnia, Psychiatric Annals, vol. 38 no. 9 (September, 2008), pp. 615-620, ISSN 0048-5713
  199. Krystal, AD; Goforth, HW; Roth, T, Effects of antipsychotic medications on sleep in schizophrenia., International Clinical Psychopharmacology, vol. 23 no. 3 (May, 2008), pp. 150-160, ISSN 0268-1315
  200. Pollack, M; Kinrys, G; Krystal, A; McCall, WV; Roth, T; Schaefer, K; Rubens, R; Roach, J; Huang, H; Krishnan, R, Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder., Arch Gen Psychiatry, vol. 65 no. 5 (May, 2008), pp. 551-562, ISSN 0003-990X
  201. Edinger, JD; Means, MK; Carney, CE; Krystal, AD, Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia., Sleep, vol. 31 no. 5 (May, 2008), pp. 599-607, ISSN 0161-8105
  202. Krystal, JH; Carter, CS; Geschwind, D; Manji, HK; March, JS; Nestler, EJ; Zubieta, J-K; Charney, DS; Goldman, D; Gur, RE; Lieberman, JA; Roy-Byrne, P; Rubinow, DR; Anderson, SA; Barondes, S; Berman, KF; Blair, J; Braff, DL; Brown, ES; Calabrese, JR; Carlezon, WA; Cook, EH; Davidson, RJ; Davis, M; Desimone, R; Drevets, WC; Duman, RS; Essock, SM; Faraone, SV; Freedman, R; Friston, KJ; Gelernter, J; Geller, B; Gill, M; Gould, E; Grace, AA; Grillon, C; Gueorguieva, R; Hariri, AR; Innis, RB; Jones, EG; Kleinman, JE; Koob, GF; Krystal, AD; Leibenluft, E; Levinson, DF; Levitt, PR; Lewis, DA; Liberzon, I; Lipska, BK; Marder, SR; Markou, A; Mason, GF; McDougle, CJ; McEwen, BS; McMahon, FJ; Meaney, MJ; Meltzer, HY; Merikangas, KR; Meyer-Lindenberg, A; Mirnics, K; Monteggia, LM; Neumeister, A; O'Brien, CP; Owen, MJ; Pine, DS; Rapoport, JL; Rauch, SL; Robbins, TW; Rosenbaum, JF; Rosenberg, DR; Ross, CA; Rush, AJ; Sackeim, HA; Sanacora, G; Schatzberg, AF; Shaham, Y; Siever, LJ; Sunderland, T; Tecott, LH; Thase, ME; Todd, RD; Weissman, MM; Yehuda, R; Yoshikawa, T; Young, EA; McCandless, R, It is time to take a stand for medical research and against terrorism targeting medical scientists., Biol Psychiatry, vol. 63 no. 8 (April, 2008), pp. 725-727, ISSN 0006-3223
  203. Chiang, A; Krystal, A, Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 4 no. 2 (April, 2008), pp. 155-156, ISSN 1550-9389
  204. Krystal, AD; Erman, M; Zammit, GK; Soubrane, C; Roth, T; ZOLONG Study Group,, Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study., Sleep, vol. 31 no. 1 (January, 2008), pp. 79-90, ISSN 0161-8105
  205. Krystal, AD; Thakur, M; Roth, T, Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia., Ann Clin Psychiatry, vol. 20 no. 1 (2008), pp. 39-46
  206. Walsh, JK; Krystal, AD; Amato, DA; Rubens, R; Caron, J; Wessel, TC; Schaefer, K; Roach, J; Wallenstein, G; Roth, T, Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations., Sleep, vol. 30 no. 8 (August, 2007), pp. 959-968, ISSN 0161-8105
  207. Roth, T; Krystal, AD; Lieberman, JA, Long-term issues in the treatment of sleep disorders, Primary Psychiatry, vol. 14 no. 7 (July, 2007), pp. 1-14, ISSN 1082-6319
  208. Roth, T; Krystal, AD; Lieberman, JA, Long-term issues in the treatment of sleep disorders., Cns Spectrums, vol. 12 no. 7 Suppl 10 (July, 2007), pp. 1-14, ISSN 1092-8529
  209. Lim, L; Krystal, A, Psychotic disorder in a patient with central and extrapontine myelinolysis., Psychiatry and Clinical Neurosciences, vol. 61 no. 3 (June, 2007), pp. 320-322, ISSN 1323-1316
  210. Brummett, BH; Krystal, AD; Siegler, IC; Kuhn, C; Surwit, RS; Züchner, S; Ashley-Koch, A; Barefoot, JC; Williams, RB, Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality., Psychosom Med, vol. 69 no. 5 (June, 2007), pp. 396-401
  211. Krystal, AD; Thase, ME; Tucker, VL; Goodale, EP, Bupropion HCL and sleep in patients with depression, Current Psychiatry Reviews, vol. 3 no. 2 (May, 2007), pp. 123-128, Bentham Science Publishers Ltd., ISSN 1573-4005
  212. Krystal, AD; Davidson, JRT, The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder., Biological Psychiatry, vol. 61 no. 8 (April, 2007), pp. 925-927, ISSN 0006-3223
  213. Montgomery, S; Kinrys, G; Krystal, A; McCall, WV; Roth, T; Rubens, R; Schaefer, K; Roach, J; Huang, H; Krishnan, R; Pollack, M, Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia, European Psychiatry, vol. 22 (March, 2007), pp. S238-S239, Cambridge University Press (CUP)
  214. Krystal, A; Fava, M; Rubens, R; Wessel, T; Caron, J; Wilson, P; Roth, T; McCall, WV, Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 3 no. 1 (February, 2007), pp. 48-55, ISSN 1550-9389
  215. Krystal, AD, Treating the health, quality of life, and functional impairments in insomnia., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 3 no. 1 (February, 2007), pp. 63-72, ISSN 1550-9389
  216. Carney, CE; Segal, ZV; Edinger, JD; Krystal, AD, A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder., The Journal of Clinical Psychiatry, vol. 68 no. 2 (February, 2007), pp. 254-260
  217. Krystal, AD, The Morbidity of Insomnia, Cns Spectrums, vol. 12 no. S10 (January, 2007), pp. 6-8, Cambridge University Press (CUP)
  218. Brummett, BH; Krystal, AD; Ashley-Koch, A; Kuhn, CM; Züchner, S; Siegler, IC; Barefoot, JC; Ballard, EL; Gwyther, LP; Williams, RB, Sleep quality varies as a function of 5-HTTLPR genotype and stress., Psychosom Med, vol. 69 no. 7 (2007), pp. 621-624
  219. Krystal, AD, Sleep and psychiatric disorders: future directions., The Psychiatric Clinics of North America, vol. 29 no. 4 (December, 2006), pp. 1115-1130, ISSN 0193-953X
  220. Zammit, GK; Corser, B; Doghramji, K; Fry, JM; James, S; Krystal, A; Mangano, RM, Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 2 no. 4 (October, 2006), pp. 417-423, ISSN 1550-9389
  221. McCall, WV; Erman, M; Krystal, AD; Rosenberg, R; Scharf, M; Zammit, GK; Wessel, T, A polysomnography study of eszopiclone in elderly patients with insomnia., Current Medical Research and Opinion, vol. 22 no. 9 (September, 2006), pp. 1633-1642, ISSN 0300-7995
  222. Krystal, AD, Psychiatric Comorbidity: The Case for Treating Insomnia, Sleep Medicine Clinics, vol. 1 no. 3 (September, 2006), pp. 359-365, Elsevier BV, ISSN 1556-407X
  223. Fava, M; McCall, WV; Krystal, A; Wessel, T; Rubens, R; Caron, J; Amato, D; Roth, T, Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder., Biological Psychiatry, vol. 59 no. 11 (June, 2006), pp. 1052-1060, ISSN 0006-3223
  224. Walsh, JK; Perlis, M; Rosenthal, M; Krystal, A; Jiang, J; Roth, T, Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 2 no. 1 (January, 2006), pp. 35-41, ISSN 1550-9389
  225. Ancoli-Israel, S; Folks, DG; Krystal, AD; McCall, WV, Response to Dr. Finucane [2], Journal of the American Geriatrics Society, vol. 54 no. 1 (January, 2006), pp. 170-172, WILEY, ISSN 0002-8614
  226. Krystal, AD; Rogers, S; Fitzgerald, MA, Long-Term Pharmacotherapy in the Management of Chronic Insomnia, The Journal for Nurse Practitioners, vol. 2 no. 9 (January, 2006), pp. S621-S632, Elsevier BV, ISSN 1555-4155
  227. Ancoli-Israel, S; Folks, DG; Krystal, AD; McCall, WV, Advertising the new hypnotics - Response to Dr. Finucane, Journal of the American Geriatrics Society, vol. 54 no. 1 (January, 2006), pp. 170-172, BLACKWELL PUBLISHING, ISSN 0002-8614
  228. Edinger, JD; Wohlgemuth, WK; Krystal, AD; Rice, JR, Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial., Archives of Internal Medicine, vol. 165 no. 21 (November, 2005), pp. 2527-2535, ISSN 0003-9926
  229. Roth, T; Walsh, JK; Krystal, A; Wessel, T; Roehrs, TA, An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia., Sleep Medicine, vol. 6 no. 6 (November, 2005), pp. 487-495, ISSN 1389-9457
  230. Krystal, AD, The effect of insomnia definitions, terminology, and classifications on clinical practice., Journal of the American Geriatrics Society, vol. 53 no. 7 Suppl (July, 2005), pp. S258-S263, ISSN 0002-8614
  231. Wohlgemuth, WK; Krystal, AD, Hypnotics should be considered for the initial treatment of chronic insomnia. Pro., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 1 no. 2 (April, 2005), pp. 120-124, ISSN 1550-9389
  232. Krystal, AD, The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep., Sleep, vol. 28 no. 1 (January, 2005), pp. 16-17, ISSN 0161-8105
  233. McCall, WV; Perlis, ML; Tu, X; Groman, AE; Krystal, A; Walsh, JK, A comparison of placebo and no-treatment during a hypnotic clinical trial, International Journal of Clinical Pharmacology and Therapeutics, vol. 43 no. 8 (2005), pp. 355-359, Dustri-Verlgag Dr. Karl Feistle, ISSN 0946-1965
  234. Krystal, AD; Roth, T, Definitions, measurements, and management in insomnia, The Journal of Clinical Psychiatry, vol. 65 no. SUPPL. 8 (December, 2004), pp. 5-7, ISSN 0160-6689
  235. Perlis, ML; McCall, WV; Krystal, AD; Walsh, JK, Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia., The Journal of Clinical Psychiatry, vol. 65 no. 8 (August, 2004), pp. 1128-1137, ISSN 0160-6689
  236. Singh, J; Zarate, CA; Krystal, AD, Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine., Psychopharmacology, vol. 173 no. 1-2 (April, 2004), pp. 227-228, ISSN 0033-3158
  237. Krystal, AD; Walsh, JK; Laska, E; Caron, J; Amato, DA; Wessel, TC; Roth, T, The Sustained 6-Month Efficacy of Eszopiclone in the Treatment of Chronic Insomnia, Sleep, vol. 27 no. 2 (March, 2004), pp. 346-347, Oxford University Press (OUP), ISSN 0161-8105
  238. Krystal, AD; Roth, T, Introduction: Definitions, measurements, and management in insomnia., The Journal of Clinical Psychiatry, vol. 65 Suppl 8 (January, 2004), pp. 5-7, ISSN 0160-6689
  239. Ancoli-Israel, S; Benca, RM; Edinger, JD; Krystal, AD; Mendelson, W; Moldofsky, H; Petrie, J; Roth, T; Walsh, JK; Winkelman, J, Changing how we think about insomnia, The Journal of Clinical Psychiatry, vol. 65 (January, 2004), pp. 44-46, PHYSICIANS POSTGRADUATE PRESS, ISSN 0160-6689
  240. Krystal, AD, Depression and insomnia in women., Clinical Cornerstone, vol. 6 Suppl 1B (2004), pp. S19-S28, ISSN 1098-3597
  241. Krystal, AD, The changing perspective on chronic insomnia management., The Journal of Clinical Psychiatry, vol. 65 Suppl 8 (2004), pp. 20-25, ISSN 0160-6689
  242. Ancoli-Israel, S; Benca, RM; Edinger, JD; Krystal, AD; Mendelson, W; Moldofsky, H; Petrie, J; Roth, T; Walsh, JK; Winkelman, J; Special Issues Board Panel Members,, Panel discussion: changing how we think about insomnia., The Journal of Clinical Psychiatry, vol. 65 Suppl 8 (2004), pp. 44-46, ISSN 0160-6689
  243. Krystal, AD; Walsh, JK; Laska, E; Caron, J; Amato, DA; Wessel, TC; Roth, T, Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia., Sleep, vol. 26 no. 7 (November, 2003), pp. 793-799, ISSN 0161-8105
  244. Edinger, JD; Krystal, AD, Subtyping primary insomnia: is sleep state misperception a distinct clinical entity?, Sleep Medicine Reviews, vol. 7 no. 3 (June, 2003), pp. 203-214, ISSN 1087-0792
  245. Cellucci, CJ; Albano, AM; Rapp, PE; Krystal, AD, Quantitative determination of abrupt changes in dynamical systems: Illustration via identification of seizure termination in generalized tonic-clonic seizure EEG data, International Journal of Bifurcation and Chaos, vol. 13 no. 9 (January, 2003), pp. 2641-2655, World Scientific Pub Co Pte Lt
  246. Krystal, AD, Insomnia in women., Clinical Cornerstone, vol. 5 no. 3 (2003), pp. 41-50, ISSN 1098-3597
  247. Krystal, AD; Weiner, RD; Dean, MD; Lindahl, VH; Tramontozzi, LA; Falcone, G; Coffey, CE, Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 15 no. 1 (2003), pp. 27-34, ISSN 0895-0172
  248. Krystal, AD; Edinger, JD; Wohlgemuth, WK; Marsh, GR, NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes., Sleep, vol. 25 no. 6 (September, 2002), pp. 630-640, ISSN 0161-8105
  249. Wohlgemuth, WK; Edinger, JD; Krystal, AD, The best of both: Brief hypnotic use to enhance behavioral insomnia therapy, Sleep, vol. 25 (April, 2002), pp. A360-A361, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105
  250. Wohlgemuth, WK; Edinger, JD; Krystal, AD; Rice, JR, Behavioral insomnia therapy for patients with fibromyalgia, Sleep, vol. 25 (April, 2002), pp. A384-A384, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105
  251. Krystal, AD; Edinger, JD; Wohlgemuth, WK; Michaels, C, A within-subject study of the relationship of non-REM EEG spectral amplitude and the agreement between subjective and objective assessments of sleep time, Sleep, vol. 25 (April, 2002), pp. A33-A34, OXFORD UNIV PRESS INC, ISSN 0161-8105
  252. Krystal, AD; Perlis, ML; McCall, WV; Zammit, G; Hirshkowitz, M, Three-month non-nightly use of zolpidem for the treatment of primary insomnia, Sleep, vol. 25 (April, 2002), pp. A68-A68, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105
  253. Rossler, IB; Johnson, RC; Krystal, AD; Weiner, RD; Levin, ED; Logue, P; Coffey, CE; Edwards, CL, A naturalistic study of the effects of smoking on the cognitive side effects of ECT., The Journal of Ect, vol. 18 no. 1 (March, 2002), pp. 64-64, LIPPINCOTT WILLIAMS & WILKINS, ISSN 1095-0680
  254. Vidal, F; Krystal, AD; Edinger, JD; Wohlgemuth, WK, Changes in sleep architecture and the sleep EEG with aging., American Journal of Geriatric Psychiatry, vol. 10 no. 2 (March, 2002), pp. 96-97, AMER PSYCHIATRIC PRESS, INC, ISSN 1064-7481
  255. Krystal, AD; Ressler, I, The use of valerian in neuropsychiatry., Cns Spectrums, vol. 6 no. 10 (October, 2001), pp. 841-847, ISSN 1092-8529
  256. Sackeim, HA; Devanand, DP; Lisanby, SH; Nobler, MS; Prudic, J; Heyer, EJ; Ornstein, E; Weiner, RD; Krystal, AD; Coffey, CE; Greenberg, RM; Husain, M; Lite, MS; Fernandez, P; Gaines, GY, Treatment of the modal patient: does one size fit nearly all?, The Journal of Ect, vol. 17 no. 3 (September, 2001), pp. 219-222, ISSN 1095-0680
  257. Swartz, CM, ECT failure rate among specific devices., The American Journal of Psychiatry, vol. 158 no. 6 (June, 2001), pp. 973-974
  258. Krystal, AD; Weiner, RD, ECT failure rate among specific devices - Drs. Krystal and Weiner reply, The American Journal of Psychiatry, vol. 158 no. 6 (June, 2001), pp. 974-974, AMER PSYCHIATRIC PRESS, INC, ISSN 0002-953X
  259. Krystal, AD; Edinger, JD; Wohlgemuth, WK; Marsh, GR, A pilot study of the sleep EEG power spectral effects of behavioral therapy in primary insomniacs, Sleep, vol. 24 (April, 2001), pp. A62-A62, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105
  260. Krystal, AD; Holsinger, T; Weiner, RD; Steffens, DC; Coffey, CE, A naturalistic study of maintenance ECT: Implications for optimizing the inter-treatment interval., The Journal of Ect, vol. 17 no. 1 (March, 2001), pp. 79-79, LIPPINCOTT WILLIAMS & WILKINS, ISSN 1095-0680
  261. Prado, R; West, M; Krystal, AD, Multichannel electroencephalographic analyses via dynamic regression models with time-varying lag-lead structure, Journal of the Royal Statistical Society. Series C, Applied Statistics, vol. 50 no. 1 (January, 2001), pp. 95-109
  262. Prado R, West M, Krystal AD  Multichannel electroencephalographic analyses via dynamic regression models with time-varying lag-lead structure J. Royal Statistical Society C-APP Part I. 2001;50: 95-109.
  263. Krystal, AD; Holsinger, T; Weiner, RD; Coffey, CE, Prediction of the utility of a switch from unilateral to bilateral ECT in the elderly using treatment 2 ictal EEG indices., The Journal of Ect, vol. 16 no. 4 (December, 2000), pp. 327-337, ISSN 1095-0680
  264. Krystal, AD; Weiner, RD; Lindahl, V; Massie, R, The development and retrospective testing of an electroencephalographic seizure quality-based stimulus dosing paradigm with ECT., The Journal of Ect, vol. 16 no. 4 (December, 2000), pp. 338-349, ISSN 1095-0680
  265. Krystal, AD; Dean, MD; Weiner, RD; Tramontozzi, LA; Connor, KM; Lindahl, VH; Massie, RW, ECT stimulus intensity: are present ECT devices too limited?, The American Journal of Psychiatry, vol. 157 no. 6 (June, 2000), pp. 963-967, ISSN 0002-953X
  266. Krystal, AD; Weiner, RD; Luber, B; Prudic, J; Devanand, DP; Sackeim, HA, The role of the ictal EEG in ECT stimulus dosing., The Journal of Ect, vol. 16 no. 1 (March, 2000), pp. 74-74, LIPPINCOTT WILLIAMS & WILKINS, ISSN 1095-0680
  267. Zoldi, SM; Krystal, A; Greenside, HS, Stationarity and redundancy of multichannel EEG data recorded during generalized tonic-clonic seizures., Brain Topography, vol. 12 no. 3 (2000), pp. 187-200, ISSN 0896-0267
  268. Krystal, AD; West, M; Prado, R; Greenside, H; Zoldi, S; Weiner, RD, EEG effects of ECT: implications for rTMS., Depression and Anxiety, vol. 12 no. 3 (2000), pp. 157-165, ISSN 1091-4269
  269. West, M; Prado, R; Krystal, AD, Evaluation and Comparison of EEG Traces: Latent Structure in Nonstationary Time Series, Journal of the American Statistical Association, vol. 94 no. 448 (December, 1999), pp. 1083-1095, Informa UK Limited, ISSN 0162-1459
  270. Krystal, AD; Prado, R; West, M, New methods of time series analysis of non-stationary EEG data: eigenstructure decompositions of time varying autoregressions., Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology, vol. 110 no. 12 (December, 1999), pp. 2197-2206, ISSN 1388-2457
  271. Asnis, GM; Chakraburtty, A; DuBoff, EA; Krystal, A; Londborg, PD; Rosenberg, R; Roth-Schechter, B; Scharf, MB; Walsh, JK, Zolpidem for persistent insomnia in SSRI-treated depressed patients., The Journal of Clinical Psychiatry, vol. 60 no. 10 (October, 1999), pp. 668-676, ISSN 0160-6689
  272. West, M; Prado, R; Krystal, AD, Evaluation and Comparison of EEG Traces: Latent Structure in Nonstationary Time Series, Journal of the American Statistical Association, vol. 94 no. 446 (June, 1999), pp. 375-387, Informa UK Limited, ISSN 0162-1459
  273. Krystal, AD; Weiner, RD, EEG correlates of the response to ECT: a possible antidepressant role of brain-derived neurotrophic factor., The Journal of Ect, vol. 15 no. 1 (March, 1999), pp. 27-38, ISSN 1095-0680
  274. Weiner, RD; Krystal, AD, 2. ECT and Anticonvulsant Medications, The Journal of Ect, vol. 15 no. 1 (March, 1999), pp. 104-104, Ovid Technologies (Wolters Kluwer Health), ISSN 1095-0680
  275. Krystal, AD; Weiner, RD; R. Krishnan, KR, 3. Magnetic Resonance Spectroscopic Correlates of the Response to ECT, The Journal of Ect, vol. 15 no. 1 (March, 1999), pp. 103-103, Ovid Technologies (Wolters Kluwer Health), ISSN 1095-0680
  276. West, M. Prado, R. and Krystal, A.  Evaluation and comparison of EEG traces: Latent structure in non-staionary time series.  Journal of the American Statistical Association, 94:375-387, 1999.
  277. Krystal, AD; Edinger, J; Wohlgemuth, W; Marsh, GR, Sleep in peri-menopausal and post-menopausal women., Sleep Medicine Reviews, vol. 2 no. 4 (November, 1998), pp. 243-253, ISSN 1087-0792
  278. Krystal, AD; Greenside, HS; Gottschalk, A; Bauer, MS; Whybrow, PC, Low-dimensional chaos in bipolar disorder [1] (multiple letters), Archives of Internal Medicine, vol. 158 no. 5 (March, 1998), pp. 275, ISSN 0003-990X
  279. Krystal, AD; Greenside, HS, Low-dimensional chaos in bipolar disorder?, Archives of General Psychiatry, vol. 55 no. 3 (March, 1998), pp. 275-276, ISSN 0003-990X
  280. Krystal, AD; Watts, BV; Weiner, RD; Moore, S; Steffens, DC; Lindahl, V, The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient., The Journal of Ect, vol. 14 no. 1 (March, 1998), pp. 5-14, ISSN 1095-0680
  281. Krystal, AD, The clinical utility of ictal EEG seizure adequacy models, Psychiatric Annals, vol. 28 no. 1 (January, 1998), pp. 30-35, SLACK INC
  282. Krystal, A.D., (member of the U.S. Modafinil in Narcolepsy Study Group). HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. Tissue Antigens 51:96-100, 1998.
  283. Weiner, R.D., Krystal, A.D. The cognitive side-effects of ECT. Progress in Neuro- Psychopharmacology & Biological Psychiatry, in press.
  284. Krystal AD. The clinical utility of ictal EEG seizure adequacy models. Psychiatric Annals 1:30- 35, 1998.
  285. Krystal, A.D., (member of the U.S. Modafinil in Narcolepsy Study Group). Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Annals of Neurology 43:88-97, 1998.
  286. Krystal, A.D., Edinger, J., Wohlgemuth, W., Marsh, G.R. Sleep in peri-menopausal and post- menopausal women. Sleep Medicine Reviews, 2:243-253, 1998.
  287. West, M., Prado, R., Krystal, A.D. Evaluation and comparison of EEG traces: Latent structure in non-stationary time series. Journal of the American Statistical Association, in press.
  288. Krystal, A.D., Zoldi, S., Greenside, H., Prado, R., West, M., Weiner, R. The effects of ECT on the EEG: implicatons for rTMS. Progress in Neuro-Psychopharmacology & Biological Psychiatry, in press.
  289. Weiner RD, Coffey CE and Krystal AD. Electroconvulsive therapy in the medical and neurological patient. 2nd edition. IN: Psychiatric Care of the Medical Patient. (Stoudemire A, Fogel BS, Eds.), New York, Oxford University Press, in press.
  290. Krystal, A.D., Zoldi, S., Prado, R., Greenside, H.S., West, M. The spatiotemporal dynamics of generalized tonic-clonic seizure EEG data: Relevance to the clinical practice of electroconvulsive therapy. IN: Proceedings of the International Conference on Nonlinear Dynamics and Brain Functioning (Rapp, P., Ed.). In Press.
  291. Krystal, AD; Coffey, CE; Weiner, RD; Holsinger, T, Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 10 no. 2 (1998), pp. 178-186, ISSN 0895-0172
  292. Krystal, AD; Zaidman, C; Greenside, HS; Weiner, RD; Coffey, CE, The largest Lyapunov exponent of the EEG during ECT seizures as a measure of ECT seizure adequacy., Electroencephalography and Clinical Neurophysiology, vol. 103 no. 6 (December, 1997), pp. 599-606, ISSN 0013-4694
  293. Krystal, AD; Coffey, CE; Weiner, RD; Rapp, PE; Albano, A; Greenside, HS; DeMasi, M; Cellucci, C, EEG correlates of the response to ECT, Biological Psychiatry, vol. 41 (April, 1997), pp. 189-189, ELSEVIER SCIENCE INC, ISSN 0006-3223
  294. Krystal, AD; Weiner, RD; Watts, BV; Moore, S; Steffens, DC; Lindahl, V, The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient., Convulsive Therapy, vol. 13 no. 1 (March, 1997), pp. 57-58, LIPPINCOTT-RAVEN PUBL
  295. Weiner, RD; Krystal, AD; Steffens, DC, Establishing an ambulatory ECT program: Different models., Convulsive Therapy, vol. 13 no. 1 (March, 1997), pp. 49-49, LIPPINCOTT-RAVEN PUBL, ISSN 0749-8055
  296. Krystal, A.D., Watts, B.V., Weiner, R.D., Moore, S., Steffens, D., Lindahl, V. The use of flumazenil in the anxious and benzodiazepine dependent ECT patient. Convulsive Therapy 13(4)xx-xx, 1997.
  297. Edinger, J.D., Fins, A.I., Goeke, J.M., McMillan, D.K., Gersh, T.L., Krystal, A.D., McCall, W.V. The empirical identification of insomnia subtypes: A cluster analytic approach. Sleep (in press).
  298. Krystal, A.D., Weiner, R.D., Lindahl, V, Massie, R. Dosing ECT treatments on the basis of the ictal EEG: A preliminary study.
  299. Krystal, A.D., Zaidman, C., Greenside, H.S., Weiner, R.D., Coffey, C.E. The largest Lyapunov exponent of the EEG during ECT seizures as a measure of therapeutic adequacy. Electroencephalography and Clinical Neurophysiology 103:599-606, 1997.
  300. Krystal, A.D., Coffey, C.E. Neuropsychiatric considerations in the use of Electroconvulsive Therapy. Journal of Neuropsychiatry and Clinical Neurosciences 9:283-292, 1997.
  301. Krystal, A.D. The clinical utility of ictal EEG seizure adequacy models. Psychiatric Annals, 1:30-35, 1998.
  302. Krystal, A.D., Greenside, H.S. Low Dimensional Chaos in Bipolar Disorders? (Letter to the Editor) Arch. Gen. Psychiatry (in press).
  303. Krystal, A.D., Coffey, C.E., Weiner, R.D., Holsinger, T. Changes in seizure threshold over the ECT course affect therapeutic response and are detected by ictal EEG ratings. J. Neuropsychiatry & Clin. Neurosci. in press.
  304. Krystal, A.D., Weiner, R.D. EEG Correlates of the response to ECT: A possible antidepressant role of brain derived neurotrophic factor, Journal of ECT.
  305. Krystal, A.D., Holsinger, T., Weiner, R.D., Coffey, C.E., Predicting unilateral ECT response and the utility of a switch to bilateral ECT with treatment 2 ictal EEG indices.
  306. Krystal, AD; Coffey, CE, Neuropsychiatric considerations in the use of electroconvulsive therapy., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 9 no. 2 (1997), pp. 283-292, ISSN 0895-0172
  307. Zoldi, SM; Krystal, AD; Greenside, HS, Statistical analysis of redundancy and stationarity in multi-channel EEG., Journal of Mathematical Psychology, vol. 40 no. 4 (December, 1996), pp. 354-355, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, ISSN 0022-2496
  308. Krystal, AD; Greenside, HS; Weiner, RD; Gassert, D, A comparison of EEG signal dynamics in waking, after anesthesia induction and during electroconvulsive therapy seizures., Electroencephalography and Clinical Neurophysiology, vol. 99 no. 2 (August, 1996), pp. 129-140, ISSN 0013-4694
  309. Edinger, JD; Fins, AI; Goeke, JM; McMillan, DK; Gersh, TL; Krystal, AD; McCall, WV, The empirical identification of insomnia subtypes: a cluster analytic approach., Sleep, vol. 19 no. 5 (June, 1996), pp. 398-411, ISSN 0161-8105
  310. Krystal, AD; Weiner, RD; Coffey, CE; McCall, WV, Effect of ECT treatment number on the ictal EEG., Psychiatry Research, vol. 62 no. 2 (May, 1996), pp. 179-189, ISSN 0165-1781
  311. Krystal, AD; Weiner, RD; Gassert, D; McCall, WV; Coffey, CE; Sibert, T; Holsinger, T, The relative ability of three ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response., Convulsive Therapy, vol. 12 no. 1 (March, 1996), pp. 13-24, ISSN 0749-8055
  312. Coffey, CE; Weiner, RD; Krystal, AD, The anticonvulsant properties of ECT., Convulsive Therapy, vol. 12 no. 1 (March, 1996), pp. 64-64, LIPPINCOTT-RAVEN PUBL, ISSN 0749-8055
  313. Krystal, A.D., Weiner, R.D., Coffey, C.E., McCall, W.V. The effect of ECT treatment number on the ictal EEG. Psychiatry Research 62:179-189, 1996.
  314. Krystal, A.D., Zaidman, C., Greenside, H.S., Weiner, R.D., Coffey, C.E. The largest Lyapunov exponent of the EEG during ECT seizures as a measure of therapeutic adequacy.
  315. Krystal, A.D., Weiner, R.D., Gassert, D., McCall, W.V., Coffey, C.E., Sibert, T., Holsinger, T. The relative ability of 3 ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response. Convulsive Therapy 12:13-24, 1996..
  316. Krystal, A.D., Greenside, H.S., Weiner, R.D., Gassert, D. A comparison of EEG signal dynamics in waking, after anesthesia induction and during ECT seizures. Electroencephalography and Clinical Neurophysiology 99:129-140, 1996.
  317. Krystal, A.D., Greenside, H.S. Low Dimensional Chaos in Bipolar Disorders? (Letter to the Editor) Arch. Gen. Psychiatry (in press).
  318. Krystal, A.D., Coffey, C.E., Weiner, R.D., Holsinger, T. Changes in seizure threshold over the ECTcourse affect therapeutic response and are detected by ictal EEG ratings.
  319. Steffens, DC; Krystal, AD; Sibert, TE; Moore, SD; Weiner, RD, Cost effectiveness of maintenance ECT., Convulsive Therapy, vol. 11 no. 4 (December, 1995), pp. 283-284, ISSN 0749-8055
  320. Krystal, AD; Weiner, RD, ECT seizure duration: reliability of manual and computer-automated determinations., Convulsive Therapy, vol. 11 no. 3 (September, 1995), pp. 158-169, ISSN 0749-8055
  321. Coffey, CE; Lucke, J; Weiner, RD; Krystal, AD; Aque, M, Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT., Biological Psychiatry, vol. 37 no. 11 (June, 1995), pp. 777-788, ISSN 0006-3223
  322. Coffey, CE; Lucke, J; Weiner, RD; Krystal, AD; Aque, M, Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold., Biological Psychiatry, vol. 37 no. 10 (May, 1995), pp. 713-720, ISSN 0006-3223
  323. Edinger, JD; Erwin, CW; Fins, AI; Marsh, GR; Krystal, AD, Ambulatory cassette polysomnography: findings from a large cohort of drug-free insomnia patients., Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society, vol. 12 no. 3 (May, 1995), pp. 302-309, ISSN 0736-0258
  324. Krystal, A.D., Greenside, H.S., Weiner, R.D., Gassert, D. A comparison of EEG signal dynamics in waking, after anesthesia induction and during ECT seizures.
  325. Review of John S. Barlow, The Electroencephalogram: It's Patterns and Origins, MIT Press, Cambridge, 1993, Biomedical Instrumentation & Technology 29:363, 1995.
  326. Krystal, A.D., Weiner, R.D., Coffey, C.E. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J. Neuropsychiatr. and Clin. Neurosciences 7:295-303, 1995.
  327. Krystal, A.D., Weiner, R.D., Gassert, D., McCall, W.V., Coffey, C.E., Sibert, T., Holsinger, T. The relative ability of 3 ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response. Convulsive Therapy (In Press).
  328. Krystal, AD; Weiner, RD; Coffey, CE, The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 7 no. 3 (1995), pp. 295-303, ISSN 0895-0172
  329. Krystal, AD; Weiner, RD, ECT seizure therapeutic adequacy., Convulsive Therapy, vol. 10 no. 2 (June, 1994), pp. 153-164, ISSN 0749-8055
  330. Weiner, RD; Krystal, AD, The present use of electroconvulsive therapy., Annual Review of Medicine, vol. 45 (January, 1994), pp. 273-281, ISSN 0066-4219
  331. Krystal AD, Weiner RD: ECT seizure therapeutic adequacy. Convulsive Therapy 10: 153-164, 1994.
  332. Krystal H, Krystal AD: Psychoanalysis and neuroscience in relationship to dreams and creativity. In (eds., Shaw MP, Runco MA), Creativity and Affect. New Jersey: Ablex Publishing Corp., 1994.
  333. Krystal AD, Weiner RD: Low frequency ictal EEG activity and ECT therapeutic impact. Convulsive Therapy 9: 220-224, 1993.
  334. McCall WV, Edinger JD, Krystal AD, Marsh GR: Ambulatory polysomnogrophic differences in healthy and insomniac older men. Ambulatory monitoring 6: 135-140, 1993.
  335. Krystal AD, Weiner RD, McCall WV, Shelp F, Arias R, Smith P: The effects of ECT stimulus dose and electrode placement on the ictal electroencehpalogram: An intraindividual crossover study. Biological Psychiatry 34: 759-767, 1993.
  336. Weiner RD, Krystal AD: EEG monitoring of ECT seizures. In (ed Coffey CE), The Clinical Science of Electroconvulsive Therapy. Washington DC: American Psychiatric Press, Inc., pp 93-109, 1993.
  337. Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M: Seizure threshold in electroconvulsive therapy. I. Initial seizure threshold. Biological Psychiatry, in press.
  338. Krystal, AD; Weiner, RD; McCall, WV; Shelp, FE; Arias, R; Smith, P, The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study., Biological Psychiatry, vol. 34 no. 11 (December, 1993), pp. 759-767, ISSN 0006-3223
  339. Krystal, AD; Weiner, RD, Low-Frequency Ictal EEG Activity and ECT Therapeutic Impact., Convulsive Therapy, vol. 9 no. 3 (January, 1993), pp. 220-224, ISSN 0749-8055
  340. Krystal, AD; Weiner, RD; Coffey, CE; Smith, P; Arias, R; Moffett, E, EEG evidence of more "intense" seizure activity with bilateral ECT., Biological Psychiatry, vol. 31 no. 6 (March, 1992), pp. 617-621, ISSN 0006-3223
  341. McCall, WV; Erwin, CW; Edinger, JD; Krystal, AD; Marsh, GR, Ambulatory polysomnography: technical aspects and normative values., Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society, vol. 9 no. 1 (January, 1992), pp. 68-77, ISSN 0736-0258
  342. Weiner, RD; Krystal, AD; Coffey, CE; Smith, P, The electrophysiology of ECT: relevance to mechanism of action., Clinical Neuropharmacology, vol. 15 Suppl 1 Pt A (1992), pp. 671A-672A, ISSN 0362-5664
  343. Weiner, RD; Coffey, CE; Krystal, AD, The monitoring and management of electrically induced seizures., The Psychiatric Clinics of North America, vol. 14 no. 4 (December, 1991), pp. 845-869, ISSN 0193-953X
  344. Krystal, AD; McEvoy, JP, Shared features of neuroleptic malignant syndrome and alcohol abuse complications., The Journal of Clinical Psychiatry, vol. 51 no. 12 (December, 1990), pp. 523, ISSN 0160-6689
  345. Krystal, A; Krishnan, KR; Raitiere, M; Poland, R; Ritchie, JC; Dunnick, NR; Hanada, K; Nemeroff, CB, Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 2 no. 1 (1990), pp. 34-43, ISSN 0895-0172

Papers Published

  1. Scangos, K; Makhoul, G; Khambhati, AN; Sellers, KK; Chang, EF; Krystal, AD, Corticocortical Evoked Potentials and Patient Response Reveal Networks Underlying Depression, Biological Psychiatry, vol. 87 no. 9 (2020), pp. S157-S157
  2. Lunsford-Avery, JR; Krystal, AD; Carskadon, MA; Kollins, SH, SLEEP ASSOCIATED WITH EXECUTIVE FUNCTIONING AMONG ADOLESCENTS ACROSS THE ADHD CONTINUUM, Sleep, vol. 43 (2020), pp. A373-A373
  3. McCall, WV; Benca, RM; Rumble, M; Krystal, AD, DO THE SUBJECTIVE EFFECTS OF HYPNOTIC MEDICATIONS RESULT IN UNBLINDING OF TREATMENT ASSIGNMENT IN HYPNOTIC RANDOMIZED CLINICAL TRIALS?, Sleep, vol. 43 (2020), pp. A181-A181
  4. Ohayon, MM; Krystal, AD; Black, J; Shapiro, CM; Sullivan, S; Swick, TJ; Wells, CC, FACTORS ASSOCIATED WITH THE CONTINUOUS USE OF PSYCHOTROPIC TREATMENTS FOR NARCOLEPSY, Sleep, vol. 43 (2020), pp. A294-A294
  5. Ohayon, MM; Sullivan, SS; Krystal, AD; Black, J; Swick, TJ; Shapiro, CM; Wells, CC, Narcolepsy Symptoms are Highly Persistent over Time Despite Treatment, Annals of Neurology, vol. 86 (October, 2019), pp. S122-S122, WILEY
  6. Ohayon, MM; Sullivan, SS; Black, J; Krystal, AD; Shapiro, CM; Swick, TJ; Wells, CC, Longitudinal Assessment of Psychotropic Treatments for Narcolepsy, Annals of Neurology, vol. 86 (October, 2019), pp. S212-S212, WILEY
  7. Doghramji, K; Davis, CW; Patroneva, A; Schwartz, J-C; Scart-Gres, C; Robert, P; Wanaski, SP; Krystal, AD, PITOLISANT IN COMBINATION WITH OTHER MEDICATIONS FOR THE MANAGEMENT OF NARCOLEPSY, Sleep, vol. 42 (April, 2019), pp. 1 pages, OXFORD UNIV PRESS INC
  8. Ohayon, MM; Krystal, AD, SLEEP IMPACTS OF NOCTURIA IN A LONGITUDINAL STUDY, Sleep Medicine, vol. 64 (2019), pp. S284-S285
  9. Ohayon, MM; Black, J; Krystal, AD; Shapiro, CM; Swick, T; Rogan, R; Well, CC, Longitudinal Evolution of Narcolepsy Symptoms in Simplex and Multiplex Families, Annals of Neurology, vol. 84 (October, 2018), pp. S129-S130, WILEY
  10. Beaulieu-Bonneau, S; Edinger, JD; Ivers, H; Krystal, AD; Morin, CM, Weekly changes in sleep and insomnia symptoms during acute treatment of persistent insomnia with behavioural or pharmacological therapy, Journal of Sleep Research, vol. 27 (September, 2018), pp. 2 pages, WILEY
  11. Lunsford-Avery, JR; Kollins, SH; Krystal, AD, 0762 Sleeping at Home: Feasibility and Tolerability of Ambulatory Polysomnography for Use with Adolescents with Attention-Deficit/Hyperactivity Disorder, Sleep, vol. 41 no. suppl_1 (April, 2018), pp. A283-A284, Oxford University Press (OUP)
  12. Rumble, ME; Dickson, D; McCall, WV; Krystal, AD; Newman, JC; Notermann, S; Rosenquist, PB; Benca, RM, 0639 A Preliminary Report from the “REST-IT” Study: Self-reported Eveningness and Actigraphic Delayed Sleep Timing Correlate with Suicidal Ideation in Individuals with Depression and Insomnia, Sleep, vol. 41 no. suppl_1 (April, 2018), pp. A237-A238, Oxford University Press (OUP)
  13. Blanco, MB; Klopfer, PH; Krystal, AD, To arouse or not to arouse: physiological responses from active thermogenesis versus thermoconforming in hibernating dwarf lemurs, American Journal of Physical Anthropology, vol. 165 (April, 2018), pp. 30-30, WILEY
  14. Morin, CM; Edinger, JD; Krystal, AD; Beaulieu-Bonneau, S; Ivers, H; Guay, B; Cartwright, A; Solano, A; Busby, M, 0341 SEQUENTIAL THERAPIES FOR COMORBID AND PRIMARY INSOMNIA: A RANDOMIZED CONTROLLED TRIAL, Sleep, vol. 40 no. suppl_1 (April, 2017), pp. A127-A127, Oxford University Press (OUP)
  15. Edinger, JD; Manber, R; Krystal, AD; Buysse, DJ, 0335 DOES OBJECTIVE SLEEP DURATION MODERATE TREATMENT RESPONSE IN PATIENT WITH COMORBID DEPRESSION AND INSOMNIA? A REPORT FROM THE TRIAD STUDY, Sleep, vol. 40 no. suppl_1 (April, 2017), pp. A124-A124, Oxford University Press (OUP)
  16. Sateia, MJ; Buysse, D; Krystal, AD; Neubauer, DN; Heald, JL, 0395 CLINICAL PRACTICE GUIDELINE FOR THE PHARMACOLOGIC TREATMENT OF CHRONIC INSOMNIA IN ADULTS: AN AMERICAN ACADEMY OF SLEEP MEDICINE CLINICAL PRACTICE GUIDELINE, Sleep, vol. 40 no. suppl_1 (April, 2017), pp. A147-A147, Oxford University Press (OUP)
  17. Dieffenderfer, J; Krystal, A; Bozkurt, A, Shedding light to sleep studies, Smart Structures and Materials 2005: Active Materials: Behavior and Mechanics, vol. 10352 (January, 2017), SPIE, ISBN 9781510611610
  18. Manber, R; Buysse, DJ; Edinger, J; Krystal, A; Luther, JF; Wisniewski, SR; Trockel, M; Kraemer, HC; Thase, ME, Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial., The Journal of Clinical Psychiatry, vol. 77 no. 10 (October, 2016), pp. e1316-e1323
  19. Leuchter, AF; Cook, IA; Feifel, D; Goethe, JW; Husain, M; Carpenter, LL; Thase, ME; Krystal, AD; Philip, NS; Hunter, AM; Burke, WJ; Howland, RH; Sheline, YI; Aaronson, ST; Iosifescu, DV; O'Reardon, J; Gilmer, WS; Jain, R; Bugoyne, K; Massaro, J; Lisanby, SH; George, MS, Can We Use Brain Oscillations to Guide Treatment of MDD?, Biological Psychiatry, vol. 77 no. 9 (May, 2015), pp. 37S-38S, ELSEVIER SCIENCE INC, ISSN 0006-3223
  20. Valero-Sarmiento, JM; Bhattacharya, S; Krystal, A; Bozkurt, A, Towards injectable biophotonic sensors for physiological monitoring of animals, Proceedings of Ieee Sensors, vol. 2014-December no. December (December, 2014), pp. 503-506, IEEE, ISSN 1930-0395, ISBN 9781479901616
  21. Tek, C; Palmese, LB; Krystal, AD; DeGeorge, PC; Reutenauer, EL; Guloksuz, S, The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial, Biological Psychiatry, vol. 75 no. 9 (May, 2014), pp. 341S-342S, ELSEVIER SCIENCE INC, ISSN 0006-3223
  22. Deng, ZD; Peterchev, AV; Krystal, AD; Luber, B; McClintock, SM; Husain, MM; Lisanby, SH, Topography of seizures induced by electroconvulsive therapy and magnetic seizure therapy, International Ieee/Embs Conference on Neural Engineering, Ner (December, 2013), pp. 577-580, IEEE, ISSN 1948-3546, ISBN 9781467319690
  23. Krystal, AD; Preud'homme, XA; Goforth, HW, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ESZOPICLONE FOR THE TREATMENT OF INSOMNIA IN PATIENTS WITH CHRONIC LOW BACK PAIN, Sleep, vol. 35 (January, 2012), pp. A216-A216, OXFORD UNIV PRESS INC, ISSN 0161-8105
  24. Buysse, DJ; Krystal, AD; Johnston, K; Dodds, N; Yu, L; Giang, R; Pilkonis, P, SLEEP AND HEALTH-RELATED FUNCTION IN A CLINICAL SAMPLE AS MEASURED BY PROMIS (PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM), Sleep, vol. 35 (January, 2012), pp. A133-A133, OXFORD UNIV PRESS INC, ISSN 0161-8105
  25. Krystal, AD; Roth, T; Pong, A; Stet, L; Ivgy-May, N, EFFICACY AND SAFETY OF ESMIRTAZAPINE IN ELDERLY PATIENTS WITH PRIMARY INSOMNIA IN A 2-WEEK SLEEP LABORATORY TRIAL, Sleep, vol. 35 (January, 2012), pp. A222-A222, OXFORD UNIV PRESS INC, ISSN 0161-8105
  26. Roth, T; Hull, SG; Singh, NN; Steinberg, F; Krystal, AD, GENDER EFFECTS OF 1.75 MG AND 3.5 MG ZOLPIDEM TARTRATE SUBLINGUAL TABLETS FORMULATED WITH A CARBONATE-BICARBONATE BUFFER ON SLEEP ONSET FOLLOWING MIDDLE-OF-THE-NIGHT AWAKENING AND ON NEXT-DAY RESIDUAL EFFECTS, Sleep, vol. 35 (January, 2012), pp. A225-A226, OXFORD UNIV PRESS INC, ISSN 0161-8105
  27. Edinger, JD; Means, MK; Krystal, AD, ARE INSOMNIA SUFFERERS' DAYTIME DEFICITS PRODUCTS OF SUBJECTIVE DISTORTIONS?, Sleep, vol. 35 (January, 2012), pp. A230-A230, OXFORD UNIV PRESS INC, ISSN 0161-8105
  28. Edinger, JD; Means, MK; Krystal, AD, DOES HYPERAROUSAL INCREASE DAYTIME ERROR PRONENESS AMONG INSOMNIA SUFFERERS?, Sleep, vol. 35 (January, 2012), pp. A214-A214, OXFORD UNIV PRESS INC, ISSN 0161-8105
  29. Preud'homme, XA; Lohri, J; Amundsen, CL; Peterson, A; Webster, GD; Krystal, AD, NOCTURIA IN SUBJECTS WITH OVERACTIVE BLADDER SYNDROME (OAB): WHAT WAKES THEM UP?, Sleep, vol. 35 (January, 2012), pp. A309-A309, OXFORD UNIV PRESS INC, ISSN 0161-8105
  30. Herring, WJ; Snyder, E; Paradis, E; Hutzelmann, J; Liu, M-C; Snavely, D; Walsh, J; Krystal, A; Roth, T; Michelson, D, Suvorexant, an orexin receptor antagonist, in preventing symptom return in patients with insomnia after 1 year of treatment: a randomised, double-blind, placebo-controlled study, Journal of Sleep Research, vol. 21 (2012), pp. 351-351
  31. Connor, K; Budd, K; Snavely, D; Liu, K; Hutzel-Mann, J; Benca, R; Krystal, A; Roth, T; Michelson, D; Herring, WJ, Efficacy and safety of suvorexant, an orexin receptor antagonist, in patients with primary insomnia: a 3-month phase 3 trial (trial #1), Journal of Sleep Research, vol. 21 (2012), pp. 97-97
  32. Rose, JE; McClernon, FJ; Froeliger, B; Behm, FM; Preud'homme, X; Krystal, AD, Repetitive Transcranial Magnetic Stimulation (rTMS) of the Superior Frontal Gyrus Modulates Craving for Cigarettes, Biological Psychiatry, vol. 69 no. 9 (May, 2011), pp. 277S-278S, ELSEVIER SCIENCE INC, ISSN 0006-3223
  33. Palmese, LB; DeGeorge, PC; Srihari, VH; Wexler, BE; Krystal, AD; Tek, C, SLEEP PATTERNS OF INDIVIDUALS WITH SCHIZOPHRENIA, Schizophrenia Bulletin, vol. 37 (March, 2011), pp. 277-277, OXFORD UNIV PRESS, ISSN 0586-7614
  34. Lankford, A; Krystal, AD; Dorsey, B; Rogowski, R; Ludington, E; Durrence, H; Davis, CS; Roth, T, PATIENT-REPORTED SYMPTOM IMPROVEMENT IN SLEEP MAINTENANCE ENDPOINTS IN ADULT AND ELDERLY PATIENTS WITH INSOMNIA TREATED WITH DOXEPIN 3 AND 6 MG, Sleep, vol. 34 (January, 2011), pp. A175-A175, OXFORD UNIV PRESS INC, ISSN 0161-8105
  35. Preud'homme, XA; Amundsen, CL; Webster, GD; Jiang, W; Kuchibhatla, M; Krystal, AD, AUTONOMIC NERVOUS SYSTEM ACTIVITY PRECEDING NOCTURIA IN OLDER ADULTS, Sleep, vol. 34 (January, 2011), pp. A241-A241, OXFORD UNIV PRESS INC, ISSN 0161-8105
  36. Krystal, AD; Lankford, A; Dorsey, B; Rogowski, R; Ludington, E; Durrence, H; Roth, T, IMPROVEMENT IN SLEEP MAINTENANCE AND EARLY MORNING AWAKENINGS IN ADULT AND ELDERLY PATIENTS WITH INSOMNIA TREATED WITH DOXEPIN 3 AND 6 MG, Sleep, vol. 34 (January, 2011), pp. A182-A182, OXFORD UNIV PRESS INC, ISSN 0161-8105
  37. Krystal, AD; Grinnell, T; Spalding, W; Zummo, J; Schweizer, E; Marshall, RD, A POSTHOC ANALYSIS OF ESZOPICLONE EFFECTS ON CARDIOMETABOLIC INDICES OF HYPERAROUSAL IN THE TREATMENT OF PRIMARY INSOMNIA, Sleep, vol. 34 (January, 2011), pp. A175-A175, OXFORD UNIV PRESS INC, ISSN 0161-8105
  38. Manber, R; Suh, S; Buysse, DJ; Edinger, JD; Cardell, C; Cardell, J; Krystal, AD, OBSTRUCTIVE SLEEP APNEA (OSA) IN MAJOR DEPRESSIVE DISORDER, Sleep, vol. 34 (January, 2011), pp. A256-A257, OXFORD UNIV PRESS INC, ISSN 0161-8105
  39. Moore, P; Zammit, G; Yen, M; Lankford, D; Scharf, M; Rosenberg, R; Edinger, J; Krystal, A, THE INFLUENCE OF MORNINGNESS-EVENINGNESS ON LATENCY TO PERSISTENT SLEEP IN A MODEL OF TRANSIENT INSOMNIA, Sleep, vol. 32 (January, 2009), pp. A60-A60, OXFORD UNIV PRESS INC
  40. Sloane, PD; Krystal, A; Harrington, JJ; Williams, C, MR1 abnormalities and circadian rhythm disturbances in persons with dementia, Journal of the American Geriatrics Society, vol. 56 no. 4 (April, 2008), pp. S59-S59, BLACKWELL PUBLISHING
  41. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Krystal, AD; Means, MK; Radtke, RA, How valid are the DSM-IV-TR and ICSD-2 insomnia nosologies? Preliminary results from a multi-trait/multi-method diagnostic trial, Sleep, vol. 31 (January, 2008), pp. A249-A249, OXFORD UNIV PRESS INC, ISSN 0161-8105
  42. Richey, SM; Weiner, RD; Edinger, JD; Preud'homme, X; Carney, CE; Krystal, AD, Change in sleep correlates with change in post-dexamethasone cortisol in patients with refractory depression treated with ECT, Sleep, vol. 31 (January, 2008), pp. A244-A244, OXFORD UNIV PRESS INC, ISSN 0161-8105
  43. Krystal, AD; Scharf, MB; Mordy, C; Singh, N; Maytom, M, Pharmacokinetics of a low dose, sublingual formulation of zolpidem tartrate in elderly subjects, Sleep, vol. 31 (January, 2008), pp. A234-A235, OXFORD UNIV PRESS INC, ISSN 0161-8105
  44. Krystal, AD; Kahn, R; Maguire, Y; Singh, N; Maytom, M, A pharmacokinetic study of the co-administration of a high fat meal with a low dose, sublingual formulation of zolpidem tartrate, Sleep, vol. 31 (January, 2008), pp. A34-A34, OXFORD UNIV PRESS INC, ISSN 0161-8105
  45. Ohayon, MM; Guilleminault, C; Black, J; Wells, C; Krystal, AD, Evolution of narcolepsy symptoms in families, Sleep, vol. 31 (January, 2008), pp. A213-A213, OXFORD UNIV PRESS INC, ISSN 0161-8105
  46. Rosenberg, R; Krystal, AD; Novak, J; Maguire, Y; Mordy, C; Singh, N; Maytom, M, Frequency and timing of middle-of-the-night (MOTN) awakenings as described using an interactive voice response system, Sleep, vol. 31 (January, 2008), pp. A235-A235, OXFORD UNIV PRESS INC, ISSN 0161-8105
  47. Roth, T; Krystal, AD; Maguire, Y; Singh, N; Maytom, M, Pharmacokinetics of the sublingual zolpidem tartrate 3.5mg lozenge compared to the oral zolpidem tartrate 10 mg tablet, Sleep, vol. 31 (January, 2008), pp. A235-A235, OXFORD UNIV PRESS INC, ISSN 0161-8105
  48. Carney, CE; Edinger, JD; Olsen, MK; Stechuchak, KM; Krystal, AD; Wyatt, JK, Inter-rater reliability for insomnia diagnoses derived from the duke structured interview for sleep disorders, Sleep, vol. 31 (January, 2008), pp. A250-A250, OXFORD UNIV PRESS INC, ISSN 0161-8105
  49. Krystal, AD; Dinges, DF, Modafinil improves performance requiring sustained attention in patients with narcolepsy, Annals of Neurology, vol. 62 (January, 2007), pp. S80-S80, WILEY-LISS, ISSN 0364-5134
  50. Janicak, PG; Nahas, Z; Lisanby, S; Solvason, HB; Sampson, S; McDonald, W; Marangell, L; Rosenquist, P; McCall, V; Kimball, J; O'Reardon, J; Loo, C; Husain, M; Krystal, A; Gilmer, W; Demitrack, M; Schatzberg, A, Durability of acute response to TMS in the treatment of major depression: Relapse during a continuation pharmacotherapy extension study, Biological Psychiatry, vol. 61 no. 8 (2007), pp. 176S-176S
  51. Krystal, A; Fava, M; Pollack, M; Rubens, R; Schaefer, K; Amato, D; Roth, T, Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia co-existing with major depressive disorder or generalized anxiety disorder, Biological Psychiatry, vol. 61 no. 8 (2007), pp. 84S-84S
  52. Aaronson, S; Avery, D; Canterbury, R; Daskalakis, ZJ; Demitrack, MA; Fitzgerald, P; George, MS; Gilmer, WS; Gutierrez, R; Husain, MM; Isenberg, K; Janicak, P; Krystal, A; Lisanby, SH; Loo, C; Maixner, D; Marangell, L; McDonald, W; Nahas, Z; O'Reardon, JP; Richelson, E; Rosenquist, P; Sackeim, H; Sampson, S; Solvason, HB, Transcranial magnetic stimulation: Effectiveness and safety in a randomized, controlled, multisite clinical trial and an open-label extension study, Neuropsychopharmacology, vol. 31 (December, 2006), pp. S230-S230, NATURE PUBLISHING GROUP
  53. Carney, CE; Edinger, JD; Krystal, AD; Stepanski, EJ; Kirby, A, Are insomnia patients pathologically worried or simply worried about sleep?, Sleep, vol. 29 (January, 2006), pp. A234-A234, OXFORD UNIV PRESS INC, ISSN 0161-8105
  54. Carney, CE; Edinger, JD; Krystal, AD; Stepanski, EJ; Kirby, A, The contribution of anxiety to sleep quality reporting in insomnia subtypes, Sleep, vol. 29 (January, 2006), pp. A233-A233, OXFORD UNIV PRESS INC, ISSN 0161-8105
  55. Rubens, R; Krystal, AD; Wessel, TC; Roth, T; Caron, J; Amato, DA, Efficacy of eszopiclone in the treatment of sleep maintenance insomnia, Neurology, vol. 64 no. 6 (March, 2005), pp. A46-A46, LIPPINCOTT WILLIAMS & WILKINS, ISSN 0028-3878
  56. Wessel, TC; Roth, T; Krystal, AD; Caron, J; Amato, DA, Twelve months of nightly eszopiclone treatment in patients with chronic insomnia: Assessment of long-term efficacy and safety, Neurology, vol. 64 no. 6 (March, 2005), pp. A46-A46, LIPPINCOTT WILLIAMS & WILKINS, ISSN 0028-3878
  57. Litsch, S; Michaels, C; Carney, C; Edinger, JJ; Wohlgemuth, WK; Krystal, AD, A pilot study of the sleep EEG power spectral effects of relaxation training in primary insomniacs, Sleep, vol. 28 (January, 2005), pp. A255-A255, OXFORD UNIV PRESS INC, ISSN 0161-8105
  58. Wohlgemuth, WK; Edinger, JD; Krystal, AD; Rice, JR, Behavioral insomnia therapy for patients with fibromyalgia: An update, Sleep, vol. 26 (May, 2003), pp. A368-A368, AMER ACADEMY SLEEP MEDICINE, ISSN 0161-8105
  59. Walsh, JK; Lankford, DD; Krystal, A; Roth, T; Jochelson, P; Garber, M; Alexander, T; Burke, J, Efficacy and tolerability of four doses of indiplon (NBI-34060) modified-release in elderly patients with sleep maintenance insomnia, Sleep, vol. 26 (May, 2003), pp. A78-A78, AMER ACADEMY SLEEP MEDICINE
  60. Becker, PM; Jamieson, AO; Jewel, CE; Bogan, RK; James, DS; Sutton, JT; Corser, B; Mayleben, DW; Bernard, SH; Dinner, DS; Emsellem, H; Knight, E; Erwin, CW; Krystal, AD; Radtke, RA; Farrow, S; Odynski, T; Pinto, J; Steljes, D; Feldman, NT; O'Brien, M; Fredrickson, PA; Kaplan, J; Lin, SC; Burger, C; Fry, JM; Guilleminault, C; Black, J; Green, PM; Schmitigal, L; Gross, PT; Dignan, S; Harsh, J; Hartwig, G; Haynes, JB; Hageman, M; Porter-Shirley, K; Hertz, G; Hirshkowitz, M; Moore, CA; Iyer, V et al., Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group., Neurology, vol. 54 no. 5 (March, 2000), pp. 1166-1175, Ovid Technologies (Wolters Kluwer Health), ISSN 0028-3878
  61. Fry,, Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy, Annals of Neurology, vol. 43 no. 1 (January, 1998), pp. 88-97, WILEY, ISSN 0364-5134
  62. KRYSTAL, AD; WEINER, RD, THE LARGEST LYAPUNOV EXPONENT OF THE EEG IN ECT SEIZURES, edited by Duke, DW; Pritchard, WS, Proceedings of the Conference on Measuring Chaos in the Human Brain (January, 1991), pp. 113-&, WORLD SCIENTIFIC PUBL CO PTE LTD, ISBN 981-02-0701-8